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This dissertation is a compilation of three studies that were conducted to better 1) Further 
validate a thoroughly tested Framingham Risk Score (FRS) on a unique cohort with 
comprehensive measures available, 2) Update and improve the predictability of the FRS 
through the addition of cardiorespiratory fitness (CRF) while resolving limitations in 
previous studies, and 3) Assess the predictability of non-exercise estimated CRF (e-CRF) 
and FRS on CHD. A manuscript was generated for each study utilizing data from the 
Aerobics Center Longitudinal Study.  
To validate the FRS, a multivariable Cox Proportional Hazard Model was used to 
determine the association between FRS component and CHD. The Area Under the Curve 
(c-statistic) from the receiver operating characteristic (ROC) curve was used to determine 
predictability of the FRS model on ACLS. The FRS’ components were significantly 
associated with CHD and the c-statistic was statistically significant.  
The second study’s goal was to update the FRS by adding CRF. This study 
included 29,854 men from ACLS that completed a baseline examination from 1979-
2002. FRS was defined as a composite score and modeled as a continuous and categorical 
variable. CRF was defined as a continuous variable through maximally achieved 
metabolic equivalent of task (METs) and categorical: low, moderate, or high CRF. 




CHD. Although the second study found there was a significant relationship with CRF, 
FRS, and CHD, traditionally measured CRF is not a clinically viable tool.  
The third study aim was to use a non-exercise estimated CRF (e-CRF) to 
determine the relationship between e-CRF, FRS, and CHD. Estimated CRF was defined 
through a 5-item questionnaire and the same data from study #2 was utilized for the 
multivariable Cox Proportional Hazard modeling. The relationship between e-CRF and 
CHD was investigated in subset populations based on age, smoking, hypertension, and 
diabetes diagnosis. Our study found that among men with ‘moderate or high’ risk for 
CHD, men with moderate or high fitness had a decreased risk for CHD compared to men 
with low fitness.  
CHD is one of the leading causes of death in the U.S. and early establishment of 
CHD risk is important for primary and secondary prevention. The series of papers 
presented in this dissertation provide the evidence needed to begin establishing a more 
comprehensive and clinically feasible risk prediction tool. Clinicians may want to 
consider capturing their patients’ medical history, CHD risk factors, and their e-CRF so 
they can take advantage of CRF’s improved prediction of CHD. This comprehensive 
approach can help physicians predict adverse events for their patients while also 
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Statement of the Problem 
Cardiovascular diseases (CVDs), including coronary heart disease (CHD) and stroke, 
represent the leading cause of death in the United States. 
1
  CVDs account for 
approximately 17% of the overall national health care expenditures. 
1-3
 The American 
Heart Association (AHA) stated in 2004 that their goal for 2010 is to “…reduce coronary 
heart disease (CHD), stroke, and risk by 25%” utilizing the following indicators: reduce 
death rate due to CHD and stroke 25%, reduce prevalence of associated risk factors 
(smoking, physical inactivity, high cholesterol, and high blood pressure), and eliminate 
the progression of obesity and diabetes. 
4
  The AHA recognized the need to expand their 
2010 goals for their 2020 proposal. AHA decided to broaden its scope beyond CHD to 
include all of cardiovascular disease (CVD) mortality and CVD health. The 2020 goal of 
the American Heart Association is to reduce the deaths caused by CVD and stroke by 
20% 
5
  and to improve the cardiovascular health of Americans by 20%.   
The AHA estimates that more than one in three adults have one or more types of 
CVD with approximately 50% of this population over the age of 59 years. 
5
 Within the 45 




leading conditions that caused those disabilities. Disability was defined as difficulty with 
daily activities and limitation in ability to do work around the house or on the job. 
5
 
CHD is the accrual of plaque in the arteries of the heart 
6
 that supply the heart 
with blood to maintain normal cardiac function. The accumulation of plaque narrows the 
heart’s arteries forcing the heart muscle to work harder. The formation of CHD depends 
on the extent of plaque build-up, reduced blood flow, and damage caused to the heart 
muscle. The deprivation of oxygen to the heart muscle may cause dead muscle cells or 
scar tissue to form, decreasing the pump efficiency of the heart and often the 
accumulation of blood on the right side.  Another main cause of CHD is the deposition of 
fat beneath the endothelium reducing the elasticity of arteries. Decreased elasticity, 
coupled with high blood pressure, could lead to the artery hemorrhaging, also called an 
aneurysm. CHD has substantially decreased worldwide in the past 30 years 
7,8
 primarily 
due to the improvements of modifiable lifestyle characteristics. 
9,10
 The modifiable 
lifestyle characteristics include smoking, high blood pressure, and high cholesterol. 
An American Cancer Society Cancer Prevention Study compared two different 
groups derived at different time points with a 20-year gap between them: group one was 
surveyed between 1959-1965 while group two was surveyed between 1982-1988. 
11
 The 
survey of these volunteers in both groups showed that there was a noticeable decline in 
deaths related to CHD between the two sampling periods. Although both lifelong 
nonsmokers and smokers at enrollment experienced a decline in CHD mortality, the 
smokers at enrollment still had a higher mortality ratio. 
11
  These results show that 




current smokers, past smokers are still at a higher risk of CHD mortality than lifelong 
nonsmokers. 
High blood pressure can subject an individual’s arteries to increased force that 
creates microscopic tears in the walls that may develop in to scar tissue. 
6
 This scar tissue 
creates a lattice for plaque to accumulate within the artery and may eventually lead to a 
partial or full blockage. 
6
 Cholesterol is a substance that contributes to plaque formation. 
12
 High cholesterol coupled with high blood pressure and scar tissue formation within 
arteries may increase an  individual’s risk for CHD. 
6,13
  Most deaths related to high 
blood pressure or high cholesterol are attributed to CHD. 
13
 It is important to note that the 
decrease of CHD mortality in recent years can be attributed to the improvement of blood 
pressure and cholesterol management. 
14
 
The body breaks down the food we consume into sugars, which it utilizes as an 
energy source. 
15
 The pancreas produces insulin that enables the cells within the body to 
utilize these sugars. 
6
 Diabetes is diagnosed when the body cannot adequately utilize 
these synthesized sugars. 
16
 Diabetes can cause impairment in the cardiac muscle that 
may lead to cardiomyopathy, congestive heart failure, or ischemic heart disease and can 
increase the 5-year mortality rate after a myocardial infarction. 
16,17
 Research shows that 
individuals with diabetes and hypertension have a higher incidence of heart disease 





Investigators from across the world have taken these and other covariates into 
consideration as they have developed risk factor scores to help model and predict an 
individual’s risk for CHD in a given time period. The Prospective Cardiovascular 




factor score encompassing age, low density lipoprotein, high density lipoprotein, 
triglycerides, smoking status, diabetes diagnosis, family history of myocardial infarction, 
and systolic blood pressure. 
20
 The Second Joint Task Force instigated the development 
of a risk score that was based on European cohorts in 12 different countries. 
21
 The result 
was a sex- and age-stratified risk chart that assessed the individual’s smoking history and 




The Framingham Heart Study developed a risk score aimed at simplifying the 
dynamic and potentially convoluted task of estimating a person’s CHD risk. 
22
 The 
Framingham Risk Score (FRS) utilized the Framingham Heart Study cohort that dates 
back to 1948. 
23
 The original risk score was derived more than forty years ago and, when 
updated in 1991, the risk factors considered remained the same: age, systolic blood 
pressure, diastolic blood pressure, cholesterol (total cholesterol and high density 
lipoproteins), smoking status, diagnosis of diabetes, and electrocardiogram to determine 
CHD risk. 
22
 The result from the FRS regression model was translated into a worksheet 
that clinicians can employ for the approximation of the five and ten year risk for CHD. 
22
 
In a recent publication from Sposito et al, 48% of surveyed physicians across the globe 
self-reported utilizing the FRS more often than other scores, 
24
 which was higher than any 
other risk score. 
An initial limitation of the FRS was the homogeneous demographic that 
comprised the Framingham Heart Study. The population recruited for the Framingham 




Hispanic White men and women. 
25
 However, since its origination, FRS or similar scores 
have been applied to various racial and ethnic populations.   
The Honolulu Heart Study was initiated in 1965with the overall concept of 
standardizing cardiovascular examination. 
26
  The cohort was comprised of Japanese men 
born between 1900 and 1919 and updated their World War II Selective Service Files; the 
final population with a baseline examination was approximately 8,000 individuals. 
26
 The 
majority of this population consisted of first generation immigrants, 50% never attended 
high school and only 15% had any technical or university training. 
26
  
Validation of the FRS also occurred in the Physician’s Health Study. Male 
physicians in the United States between 40-84 years of age (n=22,071) were randomized 
in a double-blinded, placebo-controlled study. 
27
 Coronary risk factors were collected 
through questionnaires prior to randomization and surveys were mailed to the participants 
every 6 months. Individuals would self-report nonfatal CHD incidence, and the non-
responders were followed up with a telephone-based survey. 
27
  Stampfer et al also found 
similar effects of the FRS covariates , with the exception of smoking. The Physician’s 
Health Study also reported the significant joint effect HDL and total cholesterol has on 
CHD’s relative risk. 
27,28
 
There are various risk factors that have a significant relationship with CHD and 
other cardiovascular events. However, it is not enough for these risk factors to have 
independent predictive power, the risk factor has to improve the predictability traits that 
the traditional risk score, FRS, encompasses.  Pischon et al investigated the predictive 
power of C-reactive protein (CRP) and the feasibility to substitute this for low-density 
lipoprotein cholesterol measure 
29




and then applied to the FRS. 
29
 Cox regression indicated that the FRS plus CRP was a 
significant prediction model for myocardial infarction and stroke; although the inclusion 
of CRP did not improve the predictive accuracy of the original FRS. 
29
 
Instead of attempting to modify the FRS with biological factors, Gallo et al 
evaluated augmentation of the FRS with social factors that may increase the risk of CHD. 
30
 Gallo et al. explored the effect involuntary job loss after the age of 50 years may have 
on 10-year risk on myocardial infarction and stroke. They used a Cox regression model to 
analyze the first ten years of data in the US Health and Retirement Survey with the 
outcome as self-reported myocardial infarction or stroke. Job loss was the main 
independent variable and was treated as a time dependent variable. 
30
 Gallo and his 
associates found that individuals who lost their job involuntarily had a 2.48 times higher 
risk (95% CI 1.49-4.14) for myocardial infarction and a 2.43 higher risk of stroke 
compared to individuals who did not experience involuntary job loss. 
30
 Like many 
studies that attempted to improve or modify the FRS, Gallo et al did not perform 
goodness-of-fit tests to determine if this model was truly a better predictor of 10-year 
cardiovascular disease risk than the original FRS. 
During Wilson et al’s augmentation of the 1991 FRS model, the analysis tested 
the addition of other risk factors 
25
 and considered the inclusion of physical activity or 
CRF. Unfortunately, the Framingham Heart Study did not capture this information at the 
baseline examination prohibiting its inclusion in the model. 
25
 
 Physical activity could improve an individual’s blood pressure, cholesterol levels, 
and glucose tolerance through various mechanisms. 
31
 Regular physical activity promotes 




lipoprotein cholesterol, improve the efficiency of pumping in the heart, and retard 
clotting formation within arteries. 
6,32
 From a research standpoint, measuring physical 
activity is not entirely standardized. Physical activity has been categorized differently 
across studies, which has produced variable results, thus making comparability to 
previous findings difficult. 
33
  In addition to this, the primary components that calculate 
the volume of physical activity (duration, intensity, and frequency) performed cannot be 
captured accurately. 
33
 Cardiorespiratory fitness (CRF) resolves the limitation of physical 
activity measures not being able to capture energy expenditure consistently. 
Usual physical activity habits are the primary determinant of fitness 
34
 in addition 
to CRF’s genetic component. 
35-37
  Cardiorespiratory fitness (CRF) is defined as the 
ability of the circulatory system to supply and utilize oxygen during sustained physical 
activity. 
38
 Cardiorespiratory fitness is typically measured in epidemiological studies 
through maximal or submaximal exercise tests to measure exercise capacity. 
39
 CRF has 
been shown to have a significant protective relationship for various outcomes that range 
from a diabetes diagnosis, 
34,40
 cancer morbidity, 
41





 diabetes mortality, 
40,44
 and CHD mortality. 
45,46
  
A large prospective cohort focused on determining the independent and joint 
associations CRF and obesity may have on the incidence of type 2 diabetes in American 
women. 
34
. More than 140 women developed diabetes in a 17-year follow-up period. 
34
 
Age-adjusted incidence rates were calculated for increments of CRF and the results show 
that women with a low exercise capacity (<7 METs) had a three times higher risk of 
developing type 2 diabetes compared to women with a higher exercise capacity (≥10 
METs). 
34






) unfit women (lowest CRF tertile) did not present an increased risk for 
diabetes incidence while overweight/obese (BMI≥25 kg/m
2
) unfit women had twice the 
risk for diabetes incidence; both groups were compared to the referent group comprised 
of normal weight fit women. 
34
  
CRF is also protective against all-cause mortality. More than 13,000 participants 
from the Aerobic Center Longitudinal Study (ACLS) were divided into quintiles of 
fitness and then analyzed for various joint effects of fitness and various comorbidities on 
all-cause mortality. 
43
 In men with cardiovascular disease, there was a significant 
protective linear trend relationship between CRF and all-cause mortality. 
43
 
An early study portrayed the significant effect CRF has on CHD risk factors in 
women. 
42
 Women ages 18-65 years who completed a comprehensive medical exam 
between 1971 and 1980 were included in the regression analysis to determine the 
relationship between CRF and CHD, a relationship already found to be significant in 
men. 
47-49
 The CHD risk factors employed in the analysis were based on the Framingham 
Risk Score. 
23
 CRF was shown to have significant impact on the CHD risk factors, 
including current smoking, total cholesterol, HDL cholesterol, and blood pressure. 
42
 
To better assess the risk factors for CHD mortality and the impact CRF may have, 
Lee et al (1999) conducted an analysis to examine the relationship between body 
composition, CRF, and CHD mortality. Approximately 22,000 men completed a medical 
examination between 1971 and 1989. 
46
 Body composition of these men was measured 
either through hydrostatic weighing, skinfold-thickness measurements, or both; body 
composition was defined as a three-level variable: lean (<25
th





 percentile), or obese (≥75
th




times higher risk for CHD mortality compared to fit lean men
46
. Although there were 
significantly higher risks of CHD mortality across the body composition groups, this 
significant relationship was attenuated in fit men. Fit men with a normal body 
composition had a 1.43 (95% CI 0.77, 2.67)  higher risk of CHD mortality compared to 
fit lean men while fit obese men had a 1.35(95% CI 0.66, 2.76)  times higher risk 
compared to referent group 
46
 although neither association were statistically significant.   
Gupta et al sought to determine CRF’s contribution to traditional CHD risk 
factors 
50
 and utilized the ACLS cohort with data collected from 1970 through 2006. CRF 
was defined as quintiles and the results showed that all variables included in the 
traditional risk factor score and all quintiles of CRF were significant with CHD mortality. 
50
  When comparing the traditional versus CRF-augmented model in men, the CRF-
augmented CHD risk factor model correctly reclassified participants with CHD death 
based on their 10-year risk. 
50
 However, a potential limitation of this study was the use of 
a very basic model to represent the traditional CHD risk factor model which included 
only age, systolic blood pressure, diabetes, total cholesterol, and smoking status. The 
FRS includes the covariates mentioned in Gupta et al’s report, adjusts for sex similarly to 
Gupta et al, but also includes diastolic blood pressure and high density lipoproteins in 
their risk calculation. 
22
  
Purpose and Study Aims 
 CHD is one of the leading causes of death in the United States. A diagnosis of 
CHD can cost an individual tens of thousands of dollars and shorten his or her lifespan. 
FRS provides clinicians a tool to accurately predict their patients’ 10-year risk for CHD 




protective effect on CHD as well as other comorbidities associated with CHD. The 
purpose of this study is  to further validate a thoroughly tested FRS on a unique cohort 
with comprehensive measures available; update and improve the predictability of the 
FRS through the addition of CRF while resolving limitations in previous studies; and 
asses the predictability of non-exercise estimated CRF (e-CRF) and FRS on CHD.    
 
PAPER 1: Framingham Risk Score (FRS) applied to the Aerobic Center 
Longitudinal Study (ACLS) 
Hypothesis: The Framingham Risk Score will significantly predict CHD events for men 
within the ACLS population 
PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic 
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness 
(CRF) 
Hypothesis: The CRF variable will improve the Framingham Risk Score predictive 
ability of CHD events for men within the ACLS population 
PAPER 3: Determine the association between non-exercise estimated CRF (e-CRF) 
and CHD. Utilize e-CRF and FRS to predict the risk of CHD. 
 Hypothesis: Estimated CRF (e-CRF) will be significantly protective against CHD. We 
also hypothesized that e-CRF and FRS will have a significant association with CHD. 
 
Study Outline 
 Chapter I of this dissertation has served as an introduction to the problems 




II is a review of the relevant literature. This review provides detailed insight on CHD and 
how CHD prevalence and CHD mortality incidence has changed over time. This chapter 
continues to discuss the clinical tools generated by researchers and implemented by 
physicians to help detect this problem in hopes of preventing CHD. Chapter II focuses on 
the FRS and its ability to predict a 10-year CHD risk. The chapter also points out the 
limitations of FRS and proceeds to state how this publication will correct for these 
limitations. Chapter III states the methodology employed to test the hypothesis in each of 
the three manuscripts. Chapter IV represents Paper 1 ‘Framingham Risk Score applied to 
the Aerobic Center Longitudinal Study (ACLS)’ including background, results, and 
discussion in manuscript layout. Chapter V focuses on Paper 2 ‘Augment the 
Framingham Risk Score (FRS) applied to the Aerobic Center Longitudinal Study (ACLS) 
with the addition of Cardiorespiratory Fitness (CRF)’ and reporting the results of the 
analysis aimed at augmenting FRS; this chapter is formatted similar to Chapter IV. The 
subsequent chapter, Chapter VI, captures the results from Paper 3 ‘Determine the 
association between estimated CRF (e-CRF) and CHD. Utilize e-CRF and FRS to predict 
the risk of CHD’. Chapter VII concludes the dissertation through the summation of each 
of the three presented papers and their specific hypotheses. Chapter VII also includes 
how the conclusions from each paper relate to one another, the strengths and limitations 
to the research, possible directions for future research, overall conclusions, and the 









The following literature review will reiterate findings from several studies on the severity 
of coronary heart disease, encompassing characteristics of the Framingham Risk Score, 
the positive health effects of cardiorespiratory fitness, Framingham Risk Score’s 10-year 
risk predictability of CHD events, and the potential augmentation of this risk score with 
the addition of cardiorespiratory fitness.  
Overview of Coronary Heart Disease 
Brief History 
The American Heart Association (AHA) stated in 2004 that their goal for 2010 is 
to “…reduce coronary heart disease (CHD), stroke, and risk by 25%” utilizing the 
following indicators: reduce death rate due to CHD and stroke 25%, reduce prevalence of 
associated risk factors ( smoking, physical inactivity, high cholesterol, and high blood 
pressure), and eliminate the progression of obesity and diabetes. 
4
   
Lloyd-Jones reported the progress of the reduction of CHD, stroke, high blood 
pressure, and high cholesterol depicted in Figure 2.1. 
4
 The achievement of these goals is 
partially attributed to the work practitioners and scientists conducted to improve medical 
prevention and treatment of heart disease and public health’s initiative to eliminate 
smoking and increase individuals’ physical activity while controlling their blood pressure 
and cholesterol. 
4




Figure 2.1. Trajectory of mortality rates from coronary heart disease (CHD) 
and stroke, rate of uncontrolled high blood pressure, and prevalence of high 
blood cholesterol from 2004 to 2008 (Lloyd-Jones, Adams et al. 2009)
 
Previous literature has shown an inverse relationship between physical activity 
and physical fitness and the incidence of CHD. 
48,51-53
 Clinicians seldom consider 
cardiorespiratory fitness when evaluating their patient’s risk for CHD. 
25,51
 One theory 
behind the lack of consideration CRF receives in clinical assessment of CHD is a poorly 
established association between CRF and CHD. 
51
 
A meta-analysis determined that individuals who were moderately physically 
active had a lower risk of CHD than sedentary individuals. 
54
 Following this theory, a 
more recent meta-analysis of 33 eligible studies depicted an association between CRF 
and CHD. 
51
  The individuals with a low CRF had an RR for all-cause mortality of 1.40 
(95% CI 1.23-1.48, p-value<0.001) and for CHD/CVD events of 1.47 (95%CI 1.35-1.61, 






The meta-analysis performed by Kodama, 2009 showed a dose-response 
relationship between a 1-MET increase of MAC (maximum aerobic capacity) and a 13% 
and 15% decrements in risk of all-cause mortality and CHD/CVD, respectively. 
51
  In 
categorical analysis, individuals with a low CRF had significant higher risk for 
CHD/CVD compared to individuals with intermediate or high CRF. 
51
 
Current Public Health Undertakings 
The AHA recognized the need to expand their 2010 goals for their 2020 proposal. 
AHA decided to broaden its scope beyond CHD to include all of cardiovascular disease 
(CVD) mortality and CVD health. To evaluate CHD and CVD health, a comprehensive 
metric was developed. 
4
 This metric recognized physical activity as a significant factor in 
CVD and CHD, as well as  smoking status, body mass index, diet score, cholesterol, 
blood pressure, and fasting plasma glucose. The 2020 goal of the American Heart 
Association is to reduce the deaths caused by CVD and stroke by 20% 
5
  and to improve 
the cardiovascular health of Americans by 20%.   
Health Care Costs 
The US continues to spend more money per capita than any other country on 
health care. 
55
  CHD and CVD remain among the leading causes of death in the United 
States and comprise approximately 17% of the overall national health care expenditures. 
1-3
  In the past ten years, the medical costs of CVD have grown at an average of 6% per 
year. 
56
 However the US also has observed a longer life expectancy 
57
 and as the US 




Heidenreich et al produced a detailed methodology to project and predict the 
future costs of CVD and related diseases from 2010 to 2030 (Table 1). 
55
  The CVD 
conditions that Heidenreich et al included in their analysis were hypertension, CHD, heart 
failure, and stroke. 
55
 
Table 2.1. Projections of Crude CVD Prevalence (%), 2010-2030 
in the United Stated (Heidenreich, Trogdon et al. 2011)
 
The primary data source utilized by Heidenreich and his colleagues was the 2001-
2005 Medical Expenditure Panel Survey. 
55
 Cost associated to each CVD condition was 
calculated as the difference between predicted expenditures for an individual with the 
condition compared to an individual without the condition. 
55
 Total direct (Table 2.2) and 
indirect (Table 2.3) medical costs of CVD were estimated by multiplying the per person 






Table 2.2. Projected Direct 
(Medical) Costs of CVD, 
2010-2030 (in Billions 2008$) 
in the United Stated 
(Heidenreich, Trogdon et al. 2011)
Table 2.3. Projected Indirect (Lost 
Productivity) Costs of CVD, 
2010-2030 (in Billions 2008$) in 
the United Stated (Heidenreich, 
Trogdon et al. 2011)
 
The authors also calculated indirect costs based on lost productivity for two 
reasons: CVD related morbidity, and premature mortality. 
55
 This projection determined 
that approximately 40% of the US population will have some form of CVD by the year 
2030. 
55
 This increase in CVD prevalence will result in the total direct medical costs 
tripling and indirect costs increasing from $171.1 billion to $275.8. 
55
 
The AHA estimates that more than one in three adults have one or more types of 
CVD with approximately 50% of this population over the age of 59 (Figure 2.2)
5
. Within 
the 45 million adults reporting having a functional disability, heart disease is among the 
15 leading conditions that caused those disabilities. Disability was defined as difficulty 






Figure 2.2. Incidence of cardiovascular diseases’ by age and sex 
(Framingham Heart Study, 1980-2003). Coronary heart disease, heart failure, 
stroke, or intermittent claudication. Does not include hypertension alone. 
(American Heart Association 2013)  
Quality of Care 
Institute of Medicine defines quality of care as “the degree to which health 
services for individuals and populations increase the likelihood of desired health 
outcomes and are consistent with current professional knowledge.” 
58
  There are six 
specific domains that quality of care envelops: safety, effectiveness, patient-centered, 
timely, efficient, and equitable. 
Effective care involves providing scientifically based services for those 
individuals that could benefit while refraining from causing harm to those who will not 
benefit. 
5
 Medicare data from July 2005- June 2008 was employed to determine the 30-
day mortality and 30-day readmission after hospitalization for heart failure and acute 
myocardial infarction. 
59,60
 The results showed the median risk-standardized mortality 




risk-standardized readmission rate was 24.4% and 19.9% for heart failure and acute 
myocardial infarction, respectively. 
59,60
 
Timely care is an integral factor of any CHD service and is an important service 
for health care and other industries to focus on. A study titled Can Rapid Risk 
Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early 
Implementation of the ACC/AHA Guidelines (CRUSADE) depicted that for non-ST-
elevation myocardial infarction (NSTEMI) patients, the median delay from symptom 
onset to hospital presentation was 2.6 hours. This was significantly related to within-
hospital mortality and did not change from 2001-2006. 
61
   
Biological Mechanisms 
CHD is the accrual of plaque in the arteries of the heart 
6
 that supply the heart 
with blood to maintain normal function. The accumulation of plaque narrows the heart’s 
arteries forcing the heart muscle to work harder. The form of CHD depends on the extent 
of plaque build-up, reduce blood flow, and damage caused to the heart muscle. The 
deprivation of oxygen to the heart muscle may create dead muscle cells or scar tissue to 
form, decreasing the pump efficiency of the heart and often the accumulation of blood on 
the right side.  Another main cause of CHD is the depositing of fat beneath the 
endothelium reducing the elasticity of arteries. Decreased elasticity coupled with high 
blood pressure could lead to the artery hemorrhaging, also called an aneurysm.  
Lipoprotein lipase (LPL) has been linked to the risk of CHD. 
62
 Many studies 
have documented strong inverse relationship between LPL activity and CHD 
62
. Previous 
literature has reported even slight reductions in LPL activity have increased the relative 
risk for mortality or CHD five times higher compared to healthy controls. 
63




enzyme essential for lipolysis of triglycerides and can have various effects on 
metabolism. 
64,65
 Jensen et al investigated that overexpressing LPL in the muscle fat of 
mice would prevent feeding-induced obesity by diverting the lipoprotein-derived 
triglyceride fatty acids away from being stored by the body and would then, in turn, be 
oxidized by the muscle. 
65
 Mice were examined before and after the high fat feeding 
intervention. At the conclusion of the 13 week high fat feeding, the mice that were 




A more recent rat study focused on three long-standing biological mechanisms 
associated with CHD: physical activity, insulin sensitivity, and fat storage. 
66
 Booth et al 
employed a wheel-lock model on the group of rodents. The wheel-lock model was to 
simulate the physiological changes that take place when there are changes from high 
physical activity levels to a more sedentary lifestyle. 
66
 Four week old rats were allowed 
access to running wheels for 3 weeks where they were running an average of ~5km/day 
by the third week. 
67
 The rats were then divided in to four groups: sedentary (rats who 
never run), and rats with their wheels locked for 5, 29, or 53 consistent hours. The group 
of rats with a wheel-lock for 5 hours was classified as the referent or healthy group. The 
sedentary group and the group that experienced wheel lock for 53 hours showed a 
significant reduction in insulin sensitivity compared to the referent group. Booth et al’s 
findings are concurrent with previous human studies that depicted a loss of whole-body 
sensitivity at 38 and 60 hours after termination of endurance training. 
68,69
  Figure 2.3 






 and may cause lower mitochondrial density in skeletal muscle 
resulting in metabolic dysfunction 
67
.  
Figure 2.3. A hypothetical sequence to type 2 diabetes is shown (see 
text for description) (Booth, Laye et al. 2008)
 
Patient History: Overview 
CHD has substantially decreased worldwide in the past 30 years 
7,8
 primarily due 
to the improvements of modifiable lifestyle characteristics. 
9,10
 The modifiable lifestyle 
characteristics include smoking, high blood pressure, high cholesterol, physical 
inactivity, cardiorespiratory fitness, body mass index, and diabetes mellitus. 
Patient History: Smoking 
Doyle et al published one of the first studies examining the association between 
smoking and CHD. 
71
 Doyle published findings derived from two prospective studies: 
The Framingham Study and the Albany, New York Civil Servant study and had a 
combined study population of over 1,800 men without CHD. 
71




while problems with blood pressure and cholesterol were absent, the participants that 




An American Cancer Society Cancer Prevention Study compared two different 
groups derived at different time points with a 20 year gap between them: group one was 
surveyed between 1959-1965 while group two was surveyed between 1982-1988. 
11
 The 
survey of these volunteers in both groups showed that there was a noticeable decline in 
deaths related to CHD between the two sampling periods. Although both lifelong 
nonsmokers and smokers at enrollment experienced a decline in CHD mortality, the 
smokers at enrollment still had a higher mortality risk. 
11
  
This decreasing prevalence of smoking continues. A recent 2012 article published 
in the American Journal of Public Health reported similar results from the Minnesota 
Health Study
72
. The Minnesota Health Study is a population-based cross-sectional study 
to examine the trends of risk factors associated with cardiovascular disease. The age-
adjusted prevalence of smoking significantly decreased more than 15% in both men and 
women (p-value<0.001) .
72
 National studies present similar results. 
73
 
Patient History: High Blood Pressure 
Elevated blood pressure creates more strain for the heart which can lead to 
thickening and rigidity of the muscle 
6
. This stiffness significantly increases an 
individual’s risk for a CHD. High blood pressure can also subject an individual’s arteries 
to increase force that creates microscopic tears in the walls that may develop in to scar 
tissue. 
6




may eventually lead to a partial or full blockage. 
6
  Most deaths related to high blood 
pressure are attributed to CHD .
13
 
An important cause of the decrease of CHD mortality in recent years is 
improvement of blood pressure management. 
14
 This also is supported by a recent 
publication on a population based Canadian study. They reported a 1.4 mmHg decrease 
in mean systolic blood pressure from 1994 to 2005 that could be associated with a 20% 




 Myocardial ischemia is common in patients with 
hypertension. 
16,74,75
 In early patients with hypertension, decreased ventricular relaxation 
during diastole impairs the heart’s ability to fill 
76
 while the more severe hypertensive 
cases experience myocardial wall thickness. 
16
 A continued decline in ventricular 
function could lead to heart failure. Reports from the Framingham study showed that 
hypertension was the primary cause of congestive heart failure for 35% of cases. 
77
 
Patient History: High Cholesterol 
Cholesterol is a substance that contributes to plaque formation .
12
 High cholesterol 
coupled with high blood pressure and scar tissue formation within arteries may increase 
an  individual’s risk for CHD. 
6,13
 
The aforementioned Canadian study also reported the prevention of over 1,700 
CHD deaths due to a 23% reduction in mean cholesterol level. 
14
  Data from the National 
Health and Nutrition Examination Study depicted a decrease in the mean of total 
cholesterol in the United States between two survey time points: 1988-1994 and 1999-
2000. 
78
 Hypercholesterolemia is an asymptomatic disease and regular blood screenings 
are important for detection. 
6
 Ford et al reported that nearly 60% of 20-44 year olds have 






 Ford also reports that those individuals reporting being diagnosed with 
hypercholesterolemia, only a total of 24% were regularly treating their high cholesterol 
(≥6.2 mmol/L), with men reporting a high prevalence of treatment compared to women. 
78
 
Patient History: Diabetes mellitus 
When food is consumed, it is usually broken down in to sugar for the body’s 
energy source. The pancreas produces insulin that enables the cells within the body to 
utilize these sugars. 
6
 Diabetes is diagnosed when the body cannot adequately utilize 
these synthesized sugars because of 1) reduced insulin production within the pancreas, or 
2) the body becomes insulin resistant. 
6
 Research shows that individuals with diabetes 
and hypertension have a higher incidence of heart disease compared to those with 
diabetes or hypertension alone. 
16
 Diabetes can cause impairment in the cardiac muscle 
that may lead to cardiomyopathy, congestive heart failure, or ischemic heart disease and 
can increase the 5-year mortality rate after a myocardial infarction. 
16
 Diabetic patients 
without heart disease can experience abnormal diastolic function.
79
 
Prevention of diabetes is crucial. Obesity and physical inactivity can increase the 
risk of diabetes in men and women. 
80-82
  Men and women with diabetes are at an increase 
for CHD. 
83,84
 Sullivan et al employed the Medical Expenditure Panel Survey to 
determine the association between diabetes and related comorbidities among overweight 
and inactive adults. 
82
The study was a survey conducted on a representative sample from 
the United States from 2000-2002.  Sullivan reported that inactive and obese participants 
were 5.6 (95% CI 4.2-7.8) times more likely to be diagnosed with diabetes and heart 








Patient History: Physical Inactivity 
Physical inactivity is defined by the lack of voluntary movement of skeletal 
muscles that results in energy expenditure. 
85
 and has been shown to cause chronic 
diseases 
32
 such as CHD.  Physically inactive people have twice the risk of CHD 
compared to physically active people. 
31
  Physical activity has various physiological 
mechanisms to that lead to the prevention of CHD through the improvement of blood 
pressure, cholesterol levels, and glucose tolerance. 
31,32
   
Regular physical activity promotes higher levels of high density lipoproteins that 
help control low density lipoproteins, improve the efficiency of pumping in the heart, and 
retard clotting formation within arteries. 
6,32
 
Patient History: Low Cardiorespiratory Fitness 
Cardiorespiratory fitness is associated with the ability of respiration and 





Research from the Aerobics Center Longitudinal Study (ACLS) has examined the 







 results that may be more robust across populations than fatness. 
91
  Lee et al 
reported that lean, unfit men had three times higher risk of dying from CVD(RR=3.16, 
95% CI 1.12, 8.92) compared to lean, fit men. 
46
 Lee also reports that obese, fit men’s 
risk for CVD death was not significantly different than lean, fit men. 
46
  
A meta-analysis was published  where the authors analyzed 16 different cohorts 
with combined person-years over one million. 
85
 Williams’ meta-analysis reported that fit 




with previous findings. 
43,46,88
 The association between CRF and CHD will be discussed 
in more detail later in this chapter. 
Patient History: Overweight and Obesity 
Overweight and obese status are based on a person’s body mass index. Body mass 
index (BMI) was developed by Adolphe Quetelet and is based on an individual’s body 




 Overweight is defined as a BMI of 
25.0-29.9 and a BMI of 30.0 or greater is classified as obese.  The positive trends in 
blood pressure and cholesterol control have unfortunately been partially offset by the 
increasing trends in obesity. 
14
 The prevalence of overweight and obesity has increased 
across the world, especially in the United States. 
93
 
  Excess weight can lead to an increase in uncontrolled blood pressure which, as 
previously stated, puts more strain on the heart muscle. A prospective study conducted 
with more than 115,000 female registered nurses showed that a higher BMI increases the 
risk for CHD. 
94
 This nurses’ cohort also showed that weight gain after 18 years of age 
increases the CHD risk for middle-aged women. 
94
 The relative risk for women with 
experiencing 20 or more pounds of weight gain since age 18 was 2.7 (95% CI 2.2-3.2) 
compared to women who changed less than 5 pounds since they were 18. 
94
  A meta-
analysis involving 31 cohorts concluded that calendar periods had no influence on the 
relationship between BMI and CHD and that the strongest affect was attributed to the age 








Patient History: Family History and Genetics 
First degree relatives (siblings, offspring) share roughly 50% of their genetic 
variation. 
5
 Individuals within a specified racial/ethnic group are more likely to share 
their genetic variation within their demographic group compared to other individuals 
outside their demographic group. 
5
 Roger et al also reported that 13.3% of adults 20 years 
old or greater reported having a first degree relative with a heart attack or angina before 
the age of 50. 
5
  
One limitation of investigating this relationship between family history and heart 
disease mortality worth noting is survival bias. More plainly, the risk for heart disease 
increases with age; individuals without a family history of heart disease may simply live 
longer compared to those who have a family history. Another limitation was the potential 
for recall bias. The Framingham Study performed a multigenerational cohort study 
collecting information on various health outcomes and behaviors. They reported that 
among those participants with documented parental history of heart disease, only 75%  
accurately reported their family history when asked. 
5
 
Brown et al utilized the longitudinal design of the Framingham Study and their 
inclusion of spouses and offspring of original participants to examine the heritability of 
phenotypic determinants of CVD. 
95
 The study stratified on three age groups (Age Group 
40 ± 9, Age Group 55 ± 5, and Age Group 70 ± 9) and focused on determining the 
strength of heritability of four major CVD risk factors: BMI, height, weight, and systolic 
blood pressure. 
95
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Other heritability studies from FHS shows moderate heritability in other CVD 

























) is the ratio (measured on a scale 0 to 1) of genetically caused 
variation to the total variation of a trait or measure. As h
2 
approaches 1, the heritability 
becomes stronger. 
95
 Heritability of a trait is the proportion of observable differences in a 
trait between individuals within a population that is due to genetic differences. 
Treatment 
Various treatment options for CHD are available depending on the severity of the 
problem and the underlying cause. The first form of treatment is to reduce blood pressure 
through the employment of drug therapies that regulate heartbeat, normalize cholesterol, 
or prevent blood clotting. When addressing high blood pressure, physicians also need to 
be aware of hypercholesterolemia and control this condition through lipid-lowering 
drugs. 
99
 Shepherd reported that controlling for high cholesterol significantly reduces the 
risk of a nonfatal myocardial infarction (p-value<0.0001) and produces a 32% (p-
value=0.033) reduction in death from CHD. 
99
 
More serious treatment options are available for more severe CHD cases such as 
by-passing a failed artery in the heart (heart by-pass), implementation of a stint or balloon 











A comparison analysis of Medicare data from 1992 and 2001 depicted that racial 
disparities within the high-priced CVD treatment procedures was still evident 
100
 
although minimizing in some treatment areas. In 1992 the procedure rate difference 
between White males receiving a coronary artery bypass graft compared to Black males 
was 6.29 (in favor of White males). This disparity between White and Black males was 




The recent impression cardiothoracic surgeons have is that patients being referred 
for coronary artery bypass graft are, on average, “sicker and older” than patients referred 
ten years prior. 
101
 This shift in treatment can be explained partly by extensive previous 
literature showing that lower risk patients that may only have one or two-vessel blockage 
benefit more from percutaneous coronary intervention 
102
 while clinical trials document 
that patients with a higher baseline risk (usually with triple-vessel disease) are better 
treated with coronary artery bypass graft compared to percutaneous coronary 
intervention. 
103
  Ferguson et al analyzed the data from The Society of Thoracic Surgeons 
National Cardiac Database from 1990 to 1999. This database included more than 1.5 
million adult cardiac procedures  and 520 sites. 
101
 The extensive analysis showed a 
decline in risk-adjusted mortality as well as the observed vs expected mortality ratio for 




Framingham Risk Score 
Investigators from the Framingham Heart Study have developed CHD risk 






 These equations were derived for the purpose of application on patients free 
of disease. 
23
 In 1991, the Framingham Heart Study published an update to the previous 
risk equations. 
22
 The more recent equations were derived from a more expansive data 
base which included older individuals. 
22
 The most recent risk score also accounts for the 
influence of high density lipoprotein cholesterol, a variable that the Framingham Heart 




The guidelines that were first issued by the First Joint Task Force of the European 
Societies on Coronary Prevention 
21
 was based on the Framingham Heart Study. 
22
 The 
Task Force had a number of concerns basing their risk chart on this study that included: 
1) risk function derived from US data and not European based data 2) definition of 
nonfatal endpoints in Framingham Heart Study differed from other definitions of nonfatal 
endpoints 3) difficult to adjust the model to account for local variances. 
21
 The Second 
Joint Task Force instigated the development of a risk score that was based on European 
cohorts in 12 different countries. 
21
 The result was a sex and age stratified risk chart that 
assessed the individual’s smoking history and cholesterol profile. This risk chart is aimed 
to estimate the total cardiovascular risk rather than just CHD 
21
 and enable its utilization 
in different European countries. Although this was a risk score based on several cohorts 
throughout Europe, the HeartScore still neglects to account for strong predictors of CVD 
such as a diabetes diagnosis 
80-82
 that are included in the FRS. 
Prospective Cardiovascular Münster (PROCAM) Study. 
Assmann et al reports that there are certain limitations to the Framingham Heart 






completion of the Prospective Cardiovascular Münster Study (PROCAM), which 
consisted of a cohort of middle-aged men, allowed for a risk score to be compiled to 
address Framingham’s limitations. PROCAM accounts for age, low density lipoprotein, 
high density lipoprotein, triglycerides, smoking status, diabetes diagnoses, family history 
of myocardial infarction, and systolic blood pressure to create a score ranging from zero 
to over 60. 
20
 The PROCAM risk chart adds to FRS by inclusion of family history, but 
disregards the difference men and women experience with these risk factors. This lack of 
stratification is caused by PROCAM’s limited data on only men that started collection in 




Summary of Coronary Heart Disease 
The mere presence of a risk score does not perfectly correlate with the clinical use 
and adherence to the risk score.  A 2009 report details the findings of physicians’ 
attitudes and adherence to CVD risk scores. 
24
 Sposito et al administered a survey 
throughout Europe, Africa, North America, Central America, and South America to 
physician groups commonly associated with CHD prevention: cardiologists, general 
practitioners, and endocrinologists. 
24
 The survey consisted of brief questions describing 
a hypothetical patient. Forty-eight percent of surveyed physicians indicated that they used 
a CVD risk score. 
24
 Among this 48%, the majority of physicians reported they used the 
FRS while less than a combined 15% specified other risk scores 
24





 A primary reason cited by physician’s for not utilizing these risk scores 
is that “I don’t believe they add value to the clinical evaluation.” 
24
 Sposito et al 




refinement of the current risk scores. 
24
 It is important to recognize that risk scores can 
only provide insight in to the risk of CHD and not a robust image. Currently the FRS is 
the most common CHD risk score implemented throughout the world. 
24
 FRS has been 
shown to be applicable in various race and ethnic cohorts. 
28
 Researchers have attempted 
to refine the FRS through the addition of other risk factors, only to come up with less 
meaningful conclusions than the original risk score. 
29,104-108
 All of these studies had 
various flaws including data compilation, analysis, or reporting. The current study aims 
to go beyond these limitations with a more complete, valid data base that will be utilized 
to initially assess the prediction power of FRS and then expand on its estimation power 
through the addition of cardiorespiratory fitness.  
Overview of Framingham Risk Score 
The estimation of risk for cardiovascular disease events can be a dynamic and 
convoluted task. The FHS wanted to provide a simplified method to predict the risk for 




The FHS originated in 1948 with a sample of more than 5,000 men and women 
free of coronary heart disease at the study’s initiation and residing in Framingham, 
Massachusetts. 
23
 Clinical examinations were conducted every two years. These clinical 
exams included blood chemistry values, electrocardiogram, blood pressure, physical 
exam, and a thorough cardiovascular examination. 
23
 
The original risk score was derived more than forty years ago and has since been 




well as the offspring cohort. 
22
 The inclusion criteria for the population was 1)age 30-74 
years at baseline examination; 2)data available on systolic and diastolic blood pressure, 
cigarette smoking, cholesterol levels, diabetes diagnosis, and electrocardiogram; and 3) 
individual was free of cardiovascular disease at baseline. 
23
 This study included more 
than 5,500 men and women. 
22
 The Framingham Research group updated the score a few 
years later in 1998 utilizing the same population from Anderson et al analysis. 
25
 
Derivation of Variables for Risk Score 
Host and environmental factors can contribute to coronary heart disease. These 
characteristics include atherogenic personal attributes including serum cholesterol levels, 
blood pressure, and glucose intolerance, lifestyle choices (physical inactivity and 
nutrition) that may exacerbate these attributes, and preclinical signs for cardiovascular 
disease. 
23
 When the risk factor score was updated in 1991, the risk factors considered 
remained the same: age, systolic blood pressure, diastolic blood pressure, cholesterol 
(total cholesterol and high density lipoproteins), smoking status, diagnosis of diabetes, 
and electrocardiogram to determine CHD. 
22
 Risk scores also took sex in to account 
based on previous findings that men and women experience different risks for coronary 
heart disease. 
22,23
 Blood pressure and cholesterol were defined as continuous variables, 
smoking status was dichotomized between currently smoking or quit within past 12 
months or otherwise, and diabetes was dichotomized as positive or negative diagnosis. 
22
 
Parametric regression analysis was utilized to determine significant association between 
CHD outcome and the aforementioned risk factors; Values for blood pressure and the 
ratio between HDL and total cholesterol were analyzed using the log-scale and age for 
women was transformed in to a quadratic term. 
22




was translated in to a worksheet that clinicians can employ for the approximation of the 
five and ten year risk for CHD. 
22
 
Wilson et al continued to refine this worksheet by comparing the prediction power 
of continuous risk factors versus categorized risk factors. 
25
 Blood pressure and 
cholesterol level were continuous variables for the 1991 worksheet derived by Anderson 
et al 
22
 and Wilson categorized the variables on five and four levels, respectively. 
25
 
Systolic and diastolic blood pressure was transformed in to a scale for hypertension based 
on JNC-V definition; 
109
 optimal, normal, high normal, hypertension stage I, and 
hypertension stage II and III. 
25
 The higher category for hypertension was chosen when 
systolic and diastolic fell in to different groups. 
25
 Total cholesterol was defined  as <200, 
200-239, 240-279, and ≥280 mg /dL; high density lipoprotein was defined as: <35, 35-59, 
and ≥60 mg /dL; low density lipoprotein was categorized  as follows: <130, 130-159, and 
≥160 mg /dL. 
25
 Linear regression was employed to determine the existence of significant 
trends within each risk factor 
25
 and then age-adjusted Cox Proportional Hazard Models 
were applied to test the relationship between the risk factors and the outcome of CHD 
and assigning point values based on the β-coefficients. 
25
 Wilson et al tested this 
categorization method against Anderson et al’s 1991 model that utilized continuous 
variables transformed on the log scale. Sex-specific receiver operating characteristic was 
generated for each methodology and a plot was generated to determine the difference 
between each model. 
25










The probability for developing cardiovascular disease by age 65 within the 
Framingham cohort was 37% for men and 18% for women. 
23
 The score sheet developed 
by Anderson et al assigns points to each risk factor with a point value ranging from -12 to 
19; age is the only risk factor stratified by gender. 
22
 A more detailed description can be 
seen in Table 2.4. 
Wilson et al refined Anderson et al’s score sheets to incorporate the categorized 
variables with a sex-specific final product summarizing an individual’s 10-year CHD risk 
that may range from 1% to ≥56% (see appendix Figure 3 for an example of this score 
sheet for men). 
25
 The refined score sheet produced by Wilson et al envelops the same 
predictive capability as the continuous model. 
22,25
 The categorical model also 
incorporates the categorical approach utilized by JNC-V 
109
 to measure blood pressure. 
The categorized score sheet lessens the physician burden by allowing the clinician to 
utilize either total cholesterol or low density lipoprotein. It is important to note that the 
Framingham Heart Study was a free-living population based research and the results 
might be altered if the blood pressure or cholesterol levels are aggressively treated. 
Wilson et al also evaluated the possible inclusion of other variables in this risk 
score. Family history was considered but was found not to be uniformly available within 
the birth cohort population. 
25
 The suggestion to include the presence of estrogen 
replacement therapy for postmenopausal women was made but could not be followed 
through due to a change in treatment recommendations throughout the decades. 
25,110
 
Regular physical activity and exercise are known to lower your risk of CHD. 
39,111,112
  




baseline examination and the Framingham researchers did not discuss the decision not to 









Figure 2.4. CHD score sheet for men using total cholesterol (TC) or low density 
lipoprotein cholesterol (LDL-C) categories. Uses age, TC (or LDL-C), high density 
lipoprotein cholesterol (HDL-C), blood pressure, diabetes, and smoking. Estimates risk 
for CHD over a period of 10 years based on Framingham experience in men 30 to 74 
years old at baseline. Average risk estimates are based on typical Framingham subjects, 
and estimates of idealized risk are based on optimal blood pressure, TC 160 to 199 mg/dL 
(or LDL- 100 to 129 md/dL), HDL-C of 45 mg/dL in men, no diabetes, and no smoking. 
Use of the LDL-C categories is appropriate when fasting LDL-C measurement are 







Clinical Utilization and Adherence 
Prevention of CHD and the reduction of certain risk factors can be crucial to an 
individual’s life. FRS is a tool physicians can utilize as a primary source of prevention. 
Sposito et al surveyed physicians across the globe to quantify their perspective on risk 
scores and the extent that physicians utilize the risk score. Forty-eight percent of 
respondents self-reported utilizing the FRS more often than other scores. 
24
  Of the 
remaining 52% of physicians that reported not using a risk score, approximately 75% of 
those physicians claimed the risk score ‘took up too much time’ with another 21% adding 
that they do not believe the risk score adds anything to the clinical evaluation.’ 
24
 
Physicians were also asked to apply the FRS to a hypothetical scenario.  The 
physicians were asked to rank the risk of the hypothetical scenario with the options as 
low, intermediate, or high. The results were split across the population with the majority 
(59%) of physicians ranking the hypothetical case as intermediate; most cardiologists 
classified this case as low risk. 
24
 The disagreement using the FRS varies across countries 
and ranged from 29% to 54%. 
24
 
Although there is still a large need to change physicians’ attitudes regarding the 
added benefit of risk scores, patient-physician communication and decision making is 
still the primary focus. Framingham researchers urge clinicians to exercise caution when 
generalizing the FRS. 
22,25
 One of the limitations cited from the authors and researchers 
of the Framingham Study is that the risk measure was created on an American population 
comprised of Non-Hispanic White individuals with moderate socioeconomic status. 





Validation Within Other Populations 
The population recruited for the Framingham Heart Study was derived from a 
suburb west of Boston and is comprised of primarily Non-Hispanic White men and 
women. 
25
 However, since its origination, FRS or similar scores have been applied to 
various racial and ethnic populations.   
The Honolulu Heart Study initiated in 1965with the overall concept of 
standardizing cardiovascular examination. 
26
  The cohort is comprised of Japanese men 
born between 1900 and 1919 and updated their World War II Selective Service Files; the 
final population with a baseline examination was approximately 8,000 individuals. 
26
 The 
majority of this population were first generation immigrants. 50% never attended high 
school and only 15% had any technical or university training. 
26
  
Similar to FRS, all men were free of disease with the primary outcomes consisting 
of: myocardial infarction, acute coronary insufficiency, angina pectoris, and death by 
coronary heart disease. Independent variables analyzed for inclusion in the final model 
were the same as FRS with the addition of skinfold of back and arm, and a diabetes 
diagnosis based on history of diagnosis, urinalysis, or glucose intolerance. 
26
   
Although the incidence of CHD in the Honolulu Heart Study was half the 
incidence reported in the Framingham Heart Study, the independent relationships to CHD 
were very similar. Cigarette smoking, cholesterol levels, and blood pressure all were 
significant predictors of CHD but glucose intolerance showed no significant relationship. 
26
 
Similar to the need for standardization of cardiovascular examinations  in 




Oklahoma acknowledged the inadequacy of information on cardiovascular disease on  
Native American. 
114
 Lee et al created the Strong Heart Study with an objective to use a 
retrospective cohort design and create a standardized risk estimate of cardiovascular 
disease. The study consisted of three components: 1. Mortality survey, 2.Morbidity 
survey to estimate initial and follow up hospitalizations due to myocardial infarction or 
stroke, and 3.Clinical examination .
114
 The study’s population consisted of Native 
American tribes in Arizona, North Dakota, and South Dakota. Men and women in the 
study population were segmented in to two age groups comparing 35-44 years (n=5,179) 
and 45-74 years of age (n=8,072). 
114
 The Strong Heart Study investigated similar 
covariates to the FRS and found the only significant predictive capabilities between 
diabetes diagnosis and a total cholesterol level over 280mg/dL. 
28,114
  
Validation of the Framingham Risk Factor also was done in the Physician’s 
Health Study. Male physicians in the United States between 40-84 years of age 
(n=22,071) were randomized in a double-blinded, placebo-controlled, study of beta-
carotene and aspirin. 
27
 Coronary risk factors were collected through questionnaires prior 
to randomization and surveys were mailed to the participants every 6 months. Individuals 
would self-report nonfatal CHD incidence, and the non-responders were followed up with 
a telephone based survey. 
27
  Stampfer et al also found similar effects of the FRS 
covariates with the exception of smoking. The Physician’s Health Study also reported the 
significant joint effects HDL and total cholesterol have on CHD’s relative risk. 
27,28
 
D’Agostino et al evaluated the level of agreement between the FRS applied to the 
Framingham Heart Study cohort and the FRS applied to non-Framingham Heart Study 




the predicted and actual CHD events, with the exception of the study implemented using 
the Japanese American cohort. 
28
 The suggestion from D’Agostino and his co-authors for 
future application of the FRS to non-Framingham Heart Study populations was to obtain 
the cross-sectional information on risk factor prevalence in conjunction with population 
rates of CHD over time 
28
.  However, application of the FRS to dissimilar populations is 
not the only form of modification researchers have undertaken since the FRS’s 
development.  
Potential Risk Score Modifications 
There are various risk factors that have a significant relationship with CHD and 
other cardiovascular events. However, it is not enough for these risk factors to have 
independent predictive power.  The risk factor has to improve the predictability traits that 
the traditional, FRS, encompasses.  
A recent review article assessed various risk scores that claimed to improve the 
prediction power of the Framingham Risk Score. The review contained studies that 
include one or more factors in addition to the original variables present in the FRS. 
104
 
Articles were included if they demonstrated analyses comparing the FRS performance 
against the predictive performance of the modified FRS. 
104
 The review article included 
articles making additions to the FRS: BMI, alcohol intake, and racial group; deletions 
that included diabetes diagnosis and blood pressure definition; and also the modifications 
to the definitions of smoking to include pack years, and blood pressure to include the 
prevalent hypertension diagnoses. 
104
 
Pischon et al investigated the predictive power of C-reactive protein (CRP) and 






has been shown to be a strong independent predictor of cardiovascular events including 
myocardial infarction and stroke. 
115,116
 The study population consisted of more than 
27,000 participants age 35-65 years in the city of Potsdam, Germany between the years 
1994-1998. 
29
 Myocardial infarction and stroke were self-reported by the study’s 
participants and CRP was measured through highly sensitive assays and then applied to 
the FRS. 
29
 Cox regression analysis showed that the FRS plus CRP was a significant 
prediction model for myocardial infarction and stroke although the inclusion of CRP did 
not add prediction power to the original FRS. 
29
  However, a limitation to Pischon et al’s 
publication was the lack of calibration or test for goodness-of-fit through comparison of 
the FRS to Pischon’s revised risk score.  
Ingelsson investigated apolipoprotein’s predictive power in FRS instead of 
including low-density lipoprotein. 
106
 The Framingham Offspring Study population was 
used for this analysis and the lipid measures were captured after a 12-hour fast. 
106
 The 
model including the apolipoproteins was subjected to a test for Goodness-of-Fit as well 
as model calibration. Goodness-of-Fit was analyzed through the C index produced by the 
Cox models. 
106
 The C index is calculated through the summation of the concordance 
values divided by the number of comparable pairs and has been shown to be analogous to 
the area under the curve obtained through the receiver operating characteristic curve. 
117
 
The study showed that the apolipoproteins predicted 10 year CHD risk well but there was 
no significant difference in prediction ability between the traditional cholesterol measures 
and the apolipoprotein 
106
 and therefore no benefit of the substitution. This is similar to 






Instead of attempting to modify the FRS with biological factors, Gallo et al 
studied the value of augmenting the FRS with social factors that may increase the risk of 
CHD. 
30
 Gallo et al. explored the effect of involuntary job loss after the age of 50 may 
have on 10-year risk on myocardial infarction and stroke. A Cox regression model was 
used to analyze the first ten years of data in the US Health and Retirement Survey with 
the outcome as self-reported myocardial infarction or stroke. Job loss was the main 
independent variable and was treated as a time dependent variable. 
30
 Gallo and his 
associates found that individuals who lost their job involuntarily had a 2.48 times higher 
risk (95% CI 1.49-4.14) for myocardial infarction and a 2.43 high risk of stroke 
compared to individuals who did not experience involuntary job loss. 
30
 Although this 
study displays the predictive ability of the FRS augmented with job loss, Gallo et al did 
not perform goodness-of-fit tests to determine if this model was truly a better predictor of 
10 year cardiovascular disease risk than the original FRS. 
 
Summary of Framingham Risk Score 
Framingham Risk Score has been proven to be a strong predictor of CHD risk in 
dissimilar populations. 
26-28,114
 Researchers have also attempted to improve the FRS 
through modification of current risk factors or the addition/deletion of FRS covariates 
29,30,105,106,118
 although various limitations did not allow these studies to achieve  strong 
agreement with FRS or producing a more robust predictive model than FRS.  
 During Wilson et al’s augmentation of the 1991 FRS model, the analysis tested 
the addition of other risk factors. 
25
 Physical activity has been shown to have a predictive 
effect on CHD 
32




at the baseline examination prohibiting its inclusion in the model. 
25
 Another risk factor 
that has a well-documented significant protective effect over CHD mortality and non-
fatal CHD events is cardiorespiratory fitness. 
39,43,87,88,119
  
Overview of Cardiorespiratory Fitness 
Physical Activity 
Physically active individuals have a lower risk for coronary heart disease 
compared to people less physically active. 
54
  Berlin et al conducted a meta-analysis on 
previous literature surrounding physical activity. Her analysis grouped the papers in to 
work-related and leisure physical activity while examining non-fatal coronary heart 
disease, fatal coronary heart disease, and myocardial infarction. 
54
  Summaries and 
characteristics from 27 different cohorts were analyzed to generate a Mantel-Haenszel 
Odds Ratio. 
54
 One pattern that emerged from the data was an inverse dose-response 
association; increasing physical activity decreased the risk for CHD. 
54
 In non-
occupational physical activity, nine studies reported that low physically active individuals 




A more recent meta-analysis was done by sports medicine researchers in Japan. 
Their focus was to determine the effects of physical activity on women’s health and 
preventions of CHD in women, since physical activity has been shown to have different 
effects in women and men. 
33
 Oguma and colleagues identified 30 articles originating 
from 23 different studies, the majority with a cohort study designs. 
33
 The paper 




Physical inactivity has been shown to cause CHD. 
32,67
 A recent review published 
focused on the biological mechanisms behind the link of physical activity and exercise to 
CHD. In essence, Booth and his contributors reported that the lack of physical activity or 
decrease from an active lifestyle to a sedentary lifestyle can cause a decreased turnover of 
energy stores and decreased lipid turnover causing hyperinsulinemia to occur. 
67
 
Hyperinsulinemia can lead to several other conditions including accumulation of 
adiposity in the abdominal region, insulin resistance, metabolic syndrome, and type 2 
diabetes with the latter two conditions leading to an increased risk of CHD. 
67
 
Limitations of Physical Activity 
As noted in the meta-analysis conducted by Oguma et al, measuring physical 
activity is not entirely standardized. Physical activity has been categorized differently 
across studies which may vary the results and makes comparisons to previous findings 
difficult. 
33
  In addition to this, the primary components that calculate the volume of 
physical activity (duration, intensity, and frequency) performed cannot be captured 
accurately. 
33
 This type of misclassification is common in physical activity 
120
 and can 
dilute the effect size determined between physical activity and CHD. 
33
 It could be this 
misclassification that has caused various results of physical activity’s effect on CHD and 
all-cause mortality throughout the literature. 
41
 Although Kampert et al presented that 
physical active men had a lower relative risk of all-cause mortality compared to 
physically inactive men; this significant relationship between physical activity and all-
cause mortality was not present in women. 
41
 
In a meta-analysis that examined 16 cohorts totaling more than 1 million person-




cardiorespiratory fitness may have on CHD. 
85
 The risk reduction for fitness was 
significantly greater than the risk reduction for physical activity. 
85
  This report discusses 
how physical activity and cardio respiratory fitness have significantly different 
relationships on CHD risk, although both are protective factors. 
85
  Cardiorespiratory 
fitness (CRF) resolves the limitation of physical activity measures not being able to 
capture energy expenditure consistently.  
Cardiorespiratory Fitness: Definition 
Cardiorespiratory fitness (CRF) is defined as the ability of the circulatory system 
to supply and utilize oxygen during sustained physical activity. 
38
 CRF is typically 
measured in epidemiological studies through maximal or submaximal exercise tests 
39
. 
CRF has been shown to be strongly correlated with measured maximal oxygen uptake in 
women (r=0.94) 
121
 and men (r=0.92)
122
 and is the most accepted index of CRF. 
43
 CRF is 
typically categorized using treadmill performances normalized based on age and sex. 
43
 
CRF has been shown to be protective against all-cause mortality even when taking in to 
account various health conditions. For example, Blair et al described that  current 
smokers with high CRF have reduced relative risk of all-cause mortality compared to 
current smokers with low CRF. 
43
 In an observational cohort of more than 6,000 women, 




Cardiorespiratory Fitness: Comparison with Physical Activity 
Usual physical activity habits are the primary determinant of fitness 
34
 in addition 
to CRF’s genetic component. 
35-37
 Church et al 
123




program of 4 kcal/kg a week increase in  physical activity was associated with significant 
improvement in CRF. A recent meta-analysis was performed to compare the effects 
physical activity and CRF had on CHD. 
85
 Williams plotted the relative risk (Figure 2.5) 
as functions of the cumulative percentages within the samples when ranked from least 
active or fit to most active or fit creating a weighted average for the 16 physical activity 
cohorts and seven CRF cohorts. 
85
 Physical activity presented a linear relationship with 
CHD with a 1% increase in physical activity being equivalent to a 0.0031 reduction in 
CHD relative risk. 
85
 CRF also produced a protective effect on CHD risk although, unlike 
physical activity’s relationship with CHD, CRF did not have a linear association with 
CHD and could be more appropriately described as a dose-response curve with the 
largest improvement occurring between unfit and moderate fitness. 
85
 The relative risk 
reduction for CHD was almost twice as much for CRF than for physical activity (Figure 
2.5). 
85
 This conclusion is similar to other findings and reviews of physical activity 
compared to CRF and the relationship with CHD and other outcomes such as all-cause 
mortality. 
39,124
 In preliminary multivariate modeling analyses using the Aerobic Center 
Longitudinal Study (ACLS) database, fitness still showed a significant protective 
association with all-cause mortality even when physical activity and comorbidities were 
included 
39,120
.multivariate modeling analysis employing the Aerobic Center Longitudinal 
Study (ACLS), fitness still showed a significant protective association with all-cause 






Figure 2.5. Estimated dose-response curve for the relative risk of either 
coronary heart disease (CHD) or cardiovascular disease (CVD) by 
sample percentages of fitness and physical activity. Studies weighted by 
person-years of experience (Williams 2001)
 
Cardiorespiratory Fitness: Predicting Capabilities 
All-Cause Mortality 
One of the first articles to publicize the protective relationship CRF may have on 
adverse health outcomes originated from the Aerobic Center Longitudinal Study (ACLS) 
report in 1989. 
43
 More than 13,000 participants, comprised of mainly White males, 
completed a thorough medical examination that included family history, recording of 
current medical diagnoses, blood chemistry, and maximal exercise test. The maximal 
exercise test was used to estimate maximal oxygen uptake and was performed on a 
treadmill with start position of 0% grade and 88m/min. 
43
 The treadmill increased to 2% 
after the first minute, and then 1% each minute for 25 minutes. After 25 minutes was 
completed, the incline did not change and the speed began to increase 5.4 m/min until 
termination.  The ACLS population was divided in to age and sex specific quintiles. 
43
 
Participants were followed from their first clinic visit through 1985 to determine the 
occurrence of the event, all-cause mortality. 
43




quintiles of fitness and then analyzed for joint effects of fitness and various comorbidities 
on all-cause mortality. 
43
 In men with cardiovascular disease, there was a significant 
protective linear trend relationship between CRF and all-cause mortality. 
43
 Women with 
cancer in the unfit group had a relative risk of all-cause mortality of 16.3 compared to 




The Centers for Disease Control and Prevention has predicted that American 
lifestyle and choices coupled with improved diabetes management, will result in an 
estimated prevalence of  diabetes mellitus of 48.3 million by the year 2050. 
125
 Obesity 
and physical inactivity are two strong predictors of diabetes incidence. 
80,82,126
 A large 
prospective cohort focused on determining the independent and joint associations CRF 
and obesity may have on the incidence of type 2 diabetes in American women. 
34
 More 
than 140 women developed diabetes in a 17 year follow up period. 
34
 Age-adjusted 
incidence rates were calculated for increments of CRF and the results showed that 
women with a low exercise capacity (<7 METs) had a three times higher risk of 
developing type 2 diabetes compared to women with a higher exercise capacity (≥10 
METs). 
34
 When the combined effects of CRF and BMI were analyzed, normal-weight 
(BMI <25 kg/m
2
) unfit women (lowest CRF tertile) did not present an increased risk for 
diabetes incidence while overweight/obese (BMI≥25 kg/m
2
) unfit women had twice the 
risk for diabetes incidence; both groups were compared to the referent group comprised 
of normal weight fit women. 
34
  
A similar prospective study with 18 years of follow up was conducted in men 
127
 




CRF quintiles with a fasting glucose <100 mg/dL had a 60% decreased risk of 
developing diabetes compared to unfit men with similar fasting glucose levels, 
127
 which 
was similar to findings from other study populations. 
44,112,128,129
 
Diabetes is not commonly recorded as the primary cause of death. 
130-133
 A 1992 
study reported that, among individuals with a history of diabetes,  diabetes was captured 
as the cause of death only 36% of the time. 
133,134
 A more recent study from 2006 
reported that diabetes was recorded on 39% of death certificates and was only listed as 
the underlying cause of death on 10% of decedents with diabetes. 
135
  It is much more 
likely for cardiovascular disease to be listed as the primary cause of death for individuals 
with diabetes than for diabetes to be listed as a cause of death. 
135
  
This limitation in vital statistics has led researchers to investigate all-cause or 
cardiovascular disease specific mortality within a subpopulation with a diabetes 
diagnosis. 
40,136
 All-cause mortality was the outcome of interest for a study published in 
2000 investigating the predictive effects of CRF and physical inactivity in men with type 
2 diabetes. 
136
 Average follow-up time for 1,260 diabetic men was 12 years, and it was 
noted that 180 individuals died during the study period. 
136
 A fully adjusted model 
reported that low fit, diabetic men had twice the risk of all-cause mortality compared to 
fit men. 
136
 Similarly, physically inactive men with diabetes had 1.7 times higher risk for 
all-cause mortality compared to their physically active counterparts. 
136
 
A comparable study including more than 2,300 men in a subpopulation with a 
diabetes diagnosis but no history of stroke or myocardial infarction; 179 deaths due to a 
cardiovascular event were identified in this population. 
40
 When CRF was analyzed as a 




categorized as normal weight (18.0<BMI<25.0) had a higher risk for CVD-specific 
mortality (HR 2.7, 95% CI 1.3-5.7)  compared to fit males with normal weight. This 
significant relationship was also present in low fit males classified as overweight (HR 
2.7, 95% CI 1.4-5.1) or class I obese (HR 2.8, 95% CI 1.4-5.1) 
40
. CRF’s protective 
relationship with type 2 diabetes incidence may be explained through glucose 
homeostasis. 
137,138
 CRF could assist in glucose homeostasis by improvement of blood 




A prospective observational cohort was employed to determine the relationship of 
CRF and cancer mortality. 
41
 The prospective observational study contains a large group 
of men (n=25,341) and women (n=7,080) with an average age around 42 years and 
originating from a middle to upper socioeconomic status. 
41
 The cohort is also from the 
ACLS and the method of obtaining CRF is aforementioned. 
41,43
 This report stratified 
CRF in to quintiles and concluded a significant protective linear trend for all cancer 
caused mortality for both men and women. 
120
 The treadmill maximal exercise test is an 
objective measure of fitness and minimizes the misclassification common for the 
subjective,  self-reported measures of physical activity. 
41,85
 However both have shown 
protective relationships against cancer including prostate, colon, lung, and breast cancer. 
139,140
 CRF’s strong linear protective trend against all types of cancer may be caused 
through the enhancement of the immune system. 
120
 However, Kampert et al was careful 









Self-rated health (SRH) is a subjective measure that is used to capture an 
individual’s perception of their health. This perception can incorporate biological, 
psychological, and social constructs that may be unavailable to the external observer. 
141
 
SRH has been shown to be independently associated with all-cause mortality. 
142
 In a 
recent large cohort study, SRH was also determined to have a dose-response relationship 
with CRF predicting all-cause mortality 
141
. The researchers analyzed this significant 
protective relationship taking in to account the presence of a chronic medical condition 
including diabetes, hypertension, cardiovascular disease, and cancer. 
141
  Men diagnosed 
with one or more chronic health conditions and a good/excellent SRH experienced a 
lower risk of all-cause mortality compared to men with one or more chronic health 
conditions and a poor/fair self-rated health. 
141
 The relationship between SRH and all-
cause mortality was only attenuated when CRF was added to the model. When compared 
to unfit men reporting poor/fair SRH, fit men with good/excellent SRH had a 58% 




Quality of Life 




 and chronic 
obstructive pulmonary disease,
144
 research has shown the improvement of overall quality 
of life. 
145
 Previous epidemiological studies have reported a protective association 
between CRF and quality of life. 
146-148
  Martin et al surpassed the conclusions from these 
studies and investigated the effects RF may have on quality of life with The Dose-





  This study population encompassed more than 400 women age 45-75 years. The 
women were randomized in to four different groups and the Medical Outcomes 26-Item 
questionnaire was utilized to measure quality of life. 
145
 At baseline, there were no 
significant differences in the mean scores of the DREW participants and the national 
mean. 
145
 Women were either assigned to a control group that did not perform any 
exercise, or to one of three physical activity intervention groups that expended 4, 8, or 12 
kcal/kg of body weight each week. 
145
 The results depicted a positive dose-response 
relationship between CRF and quality of life; this relationship was not attenuated by 
weight change. 
145
  As the demographics for the 65 years of age or older population begin 
to shift, this paper holds important public health implication for this sub-population. The 
aging population of the United States can benefit from exercise and improved CRF by 
preventing certain chronic conditions and improving their quality of life. 
 
Coronary Heart Disease 
A 1987 review article summarized the protective effects of habitual physical 
activity and coronary heart disease. 
149
 The review paper concluded that there was a 
significant effect between physical inactivity and CHD. 
149
 The authors continue to state 




  The lack of 
standardization leads to imprecise findings with only 66% of the reviewed literature 
showing a significant relationship. 
149
 On the other hand, CRF is a very objective measure 
with a standardized operating procedure and variable definition. 
150
 
An early study portrayed the significant effect CRF has on CHD risk factors in 
women. 
42




between 1971 and 1980 were included in the regression analysis to determine the 
relationship between CRF and CHD, a relationship already found to be significant in 
men. 
47-49
 The CHD risk factors employed in the analysis were based on the Framingham 
Risk Score. 
23
 CRF was shown to have significant impact on the CHD risk factors 
including current smoking, total cholesterol, HDL cholesterol, and blood pressure. 
42
 
Ekelund continued the study of this association through the utilization of the Lipid 
Research Clinics Prevalence Survey. 
45
 The primary aim of this study was to determine 
the relationship physical fitness, obtained through a maximal exercise test, has on 
coronary heart disease mortality. 
45
  Cox proportional hazard models were used in a 
cohort of approximately 4,000 men divided in to a healthy group and a group with 
cardiovascular disease diagnosis. 
45
  Healthy men with a higher CRF were shown to have 
a lower CHD and CVD mortality compared to healthy men with low CRF; similarly, men 
with a CVD history and low CRF are 5.6 times more likely to die from CHD (95% CI 
2.5-12.6) or 4.8 times more likely to die from CVD (95% CI 2.5-9.2) compared to men 
with a CVD history and high CRF. 
45
 Ekelund et al concluded that mortality was higher 
in the least fit group regardless of health history and that physical fitness and physical 
training improve heart rate, heart rate recovery, and improve myocardial oxygen supply. 
45
 This study provides further evidence to Oja et al’s results from a physical training 
program in men. 
47
 The men were divided up in to four training groups based on their 
preference for type of exercise with two groups serving as the control training group 
whom did not receive any exercise.  At the end of the 18 month training, a significant 
change (p-value <0.001) was seen in the experimental groups regarding their heart rate 






To better assess the risk factors for CHD mortality and the impact CRF may have, 
Lee et al (1999) conducted an analysis to examine the relationship between body 
composition, CRF, and CHD mortality. Approximately 22,000 men who completed a 
medical examination between 1971 and 1989 received a body composition assessment 
and reached ≥85% of their age-adjusted maximal heart rate during a treadmill test. 
46
 
Body composition of these men was measured either through hydrostatic weighing, 
skinfold-thickness measurements, or both and percentage of body fat was calculated with 
Siri’s 
151
 two-component model. Body composition was defined as a three level variable: 
lean (<25
th




 percentile), or obese (≥75
th
 percentile). 
Hazard ratios were adjusted for smoking habit, alcohol use, and parental history of heart 
disease with the referent group represented by fit, lean men. 
46
 A significant interaction 
was reported between body composition and CRF. Unfit lean men had a significantly 
three times higher risk for CHD mortality compared to fit lean men; unfit men with 
normal body composition had a 2.94 (95% CI 1.48, 5.83) times higher risk compared to 
fit lean men. 
46
 The largest effect was found in unfit obese men who had a four times 
higher risk for CHD mortality compared to fit lean men. 
46
 Although there were 
significantly higher risk of CHD mortality across the body composition groups, this 
significant relationship was attenuated in fit men. Fit men with a normal body 
composition had a 1.43 (95% CI 0.77, 2.67) higher risk of CHD mortality compared to fit 
lean men while fit obese men had a 1.35(95% CI 0.66, 2.76) times higher risk compared 
to referent group. 
46




Figure 2.6. Cumulative Rate of Death from Cardiovascular Disease 
in Health Men, According to Quartiles of Stage 2 Exercise Heart 
Rate (Ekelund, Haskell et al. 1988)
 
These findings build on a previous report from Ekelund et al 
45
 who investigated 
the relationship between CRF and CHD in asymptomatic men. A treadmill maximal 
exercise test was used to determine fitness category and the participants were divided in 
to four categories depending on their heart rate during the second stage of the treadmill 
test with the fourth quartile representing the least fit individuals. 
45
 The participants were 
followed for nine years for event occurrence (CHD mortality). A cumulative growth 
curve for CHD mortality depicts the most fit group (first quartile) having the least risk 
compared to the fourth quartile. 
45
  
The biological mechanisms behind this protective relationship is primarily based 
on peripheral mechanism 
152,153
 such as improvements in skeletal muscles and 
enhancement in arterial oxygen content. 
153
  Research has shown that CRF can increase 
the double-product threshold for ischemic ST-segment depression, 
154,155
 a decrease in the 
magnitude of ST depression, and a diminished maximal ST depression. 
154
 CRF may also 
have a positive effect on coagulation 
156,157






This protective relationship between CRF, CHD diagnosis, and CHD cause 
mortality has been demonstrated numerous times. 
88,111,119,123,158-161
 Despite this strong 
and continuous relationship, the American Heart Disease and Stroke do not mention 
CRF’s protective effects against CHD in their annual report. 
5,6,162
 
Cardiorespiratory Fitness: Utilization in Coronary Heart Disease Risk Factor Scores 
Barlow et al recently investigated prognostic factors of long-term cardiovascular 
risk in “low risk” men and women. 
163
 Low risk for coronary heart disease was defined 
utilizing the 10-year risk of CHD <10% by the Framingham Risk Score. 
163
 Through the 
analysis of cardiorespiratory fitness, Barlow et al showed that a 1-MET increase in CRF 
resulted in an 18% lower risk of CVD mortality during a 30 year follow up period. 
163
   
Gupta et al sought to determine CRF’s contribution to traditional CHD risk 
factors 
50
. Gupta utilized the ACLS cohort with data ranging from 1970 through 2006. 
The researchers utilized a traditional CHD risk factor model that adjusted for age, systolic 
blood pressure, diabetes, total cholesterol, and smoking status 
50
 and measured the 
predictability of the traditional model on the ACLS cohort and the predictability of the 
traditional risk factor score after the addition of CRF. Harrell’s C statistics were 
calculated for each model. All variables included in the traditional risk factor score and 
all quintiles of CRF were significant with CHD mortality. 
50
 When comparing the 
traditional versus CRF augmented model in men, the CRF augmented CHD risk factor 
model correctly reclassified participants with CHD death based on their 10-year risk 
50
. 
For instance, among male participants with CHD death, the CRF augmented risk model 






A potential limitation of this study is the use of a very basic model to represent 
the traditional CHD risk factor model. Gupta et al’s traditional CHD risk factor model 
accounts for variables that other popular models, such as the Heart Study, 
21
 do not while 
neglecting to include significant CHD risk factors that other models include.  A popular 
CHD risk factor score derived from the PROCAM cohort adjusts for similar covariates in 
Gupta et al’s study with the addition of family history of myocardial infarction, HDL, and 
LDL. 
20
 The FRS adjusts for sex similarly to Gupta et al and also includes diastolic blood 
pressure and high density lipoproteins in their risk calculation. 
22
 
Each CHD risk factor model has its own specific limitations. Gupta et al reported 
the improvement in calibration and risk classification  CRF added to their ‘traditional’ 
risk score derived from the ACLS cohort. 
50
 Other researchers have taken the FRS and 
added covariates such as apolipoproteins, 
106
 C-reactive protein, 
29
 and social factors. 
30
 
The aforementioned evidence and research states the strong protective effect CRF has on 
CHD. Previously presented literature also reports the validity of the FRS. The 
culmination of this literature suggests that the addition of CRF in the Framingham Risk 








 This research encompasses three manuscripts focusing on the predictive 
power of cardiorespiratory fitness. The overarching goal is to create a prediction equation 
that includes CRF and is modeled after the Framingham Heart Study’s Framingham Risk 
Score. Each manuscript addresses specific research topics through the utilization of the 
Aerobics Center Longitudinal Study data.  
Aerobics Center Longitudinal Study (ACLS) 
ACLS is an ongoing, cohort study that encompasses a large group of men and 
women. The participants were patients of the Cooper Clinic, where they received a 
preventative medical examination and counseling on health behaviors during periodic 
visits. The Cooper Clinic serves anyone who elects to come for an examination and 
patients come from all 50 states.  During the patients’ medical examination, they were 
informed of the ACLS cohort study, asked to participate, and, if they agreed to 
participate, consented to follow-up surveillance. 
The participants were examined at least once during 1970 to 2003 at the Cooper 
Clinic, Dallas, TX. The cohort consists of mostly individuals within the middle and upper 
socioeconomic groups with approximately 80% holding college degrees. 
41
 The mean age 




(>95%) individuals. Although a large number of women were enrolled in ACLS, the 
majority of patients were men (~75%).  The following primary inclusion criteria were 
used: 
1. Age at baseline examination between 30-74 years 
2. Complete data for outcome and predictor variables 
3. Free of CHD diagnosis or cancer diagnosis at baseline 
Women were excluded from analysis due to the small proportion of events. The 
sample population for Hypothesis I is larger compared to the sample population utilized 
for Hypothesis II and III. The change in sample size is cause by second inclusion item 
and ensuring there was not missing data. Hypothesis II and III include the CRF variable 
that is missing in 13.61% of the sample population for Hypothesis I.  
While ACLS is not a representative sample of the entire US population, a 
comparison of median values of specific physiological variables show similarity to 
representative population data. 
164
  A comparison between ACLS and two large 
population based cohorts found that ACLS’ results were similar to the results of the Lipid 
Research Clinics Prevalence Survey and the Canada Fitness Survey. 
165
 A notable 
advantage of ACLS’ homogeneity is controlling for potential confounding by 
demographic characteristics such as education, socioeconomic status, and race/ethnicity. 
Although ACLS’ homogeneity characteristic improves the internal validity, 
generalizations must be made cautiously and future research should be conducted in more 







 Trained technicians followed standardized protocols for each measurement. The 
baseline clinical exam included a personal and family medical history, anthropometric 
measurements, a 12-hour fasting blood chemistry including glucose and cholesterol 
measurements, ECG, blood pressure assessment, and a maximal exercise test 
112,164,166
. 
Smoking was assessed through a standardized questionnaire and participants were 
classified as current or non-smoker.  
 CRF was determined using the Balke maximal exercise test 
167
.  Treadmill time 
converted to METs is analogous to peak VO2 
121
 and is an accepted object laboratory 
measure of CRF. At initialization of test, the treadmill speed was 88m/min for the first 25 
minutes. The initial grade of the treadmill was set at 0%, increased to 2% after the first 
minute, and then increased 1% grade for the second minute and continued this pattern of 
progression for each subsequent minute until 25minutes elapsed. After 25 minutes, the 
treadmill’s grade remained constant and the speed increased at the rate of 5.4m/minute 
until termination of the exercise test. Technicians encouraged participants to give 
maximal effort. The following regression formula was employed to convert maximal 
treadmill time to METs 
48
: 
     
(                              )       
   
 
One MET is equal to energy expenditure of an average person at rest. 
168
 Factors other 
than physical activity may influence both health status and fitness levels through various 
biological pathways. Because of this, CRF provides an objective measure of recent 
physical activity habitat compared to self-report physical activity levels; CRF also offers 




and CRF is less prone to misclassification bias. Many ACLS participants have several 
clinical examinations at varying intervals. Table 3.1 depicts the main assessments 
included in their clinical exam and interview. 
 
 
Table 3.1.  Data available on Cooper Clinic patients (baseline and repeat visits) 
A. Demographics 
 Age, Sex, Race, Education, Income,  
      Occupation, Marital Status 
 
B. Medical History  
1.  Medication history 
3.  Brief nutritional pattern questionnaire 
4.  Alcohol intake 
5.  Extensive exercise and sports  
     participation questionnaire 
6.  Weight history 
2.  Extensive series of questions on past or  
     present diseases/conditions 
3.  Hospitalizations 
4.  Physician visits 
5.  Days lost from work 
6.  Family medical history 
 
C.  Health Habits 
1.  Smoking history 
2.  3-day diet record 
D. Laboratory 
1.  Maximal exercise treadmill test (ECG,  
heart rate, and blood pressure during  
exercise and recovery) 
2.  Pulmonary function 
3.  Body composition (7 skinfolds, girths,  
     and hydrostatic weighing) 
4.  Blood chemistries (lipids, glucose, uric  
     acid) 
5.  Urinalysis 
6.  Height and weight 
7.  Physical examination (complete  
 physician’s examination findings  
 including ECG interpretation) 
 
Framingham Risk Score (FRS) 
FRS was derived from the Framingham Heart Study, which  is an ongoing 
observational study that initiated in 1948 and primarily recruits residents of Framingham, 
Massachusetts. 
23
 The Framingham Heart Study involved clinical exams conducted every 
other year.  The inclusion criteria applied to the Framingham Heart Study to derive the 




systolic and diastolic blood pressure, cigarette smoking, cholesterol levels, diabetes 
diagnosis, and electrocardiogram and 30individual was free of cardiovascular disease at 
baseline. 
22
 The most recent FRS is presented with categorical variables for hypertension, 
total cholesterol, high density lipoprotein, smoking, and diabetes. 
25
 
The main outcome of the FRS was a CHD event defined as a myocardial 
infarction, coronary insufficiency, or CHD death. These events were recorded from self-
report or medical chart review. The original FRS has been updated since its origin in 
1976. 
23,25
 FRS stratifies by sex and adjusts for age. Age is treated as a continuous 
variable within the survival model. Anderson et al 
22
 updated the FRS and the risk factors 
included the continuous variables: systolic blood pressure, diastolic blood pressure, total 
cholesterol, high density lipoproteins, and dichotomous variables for smoking status and 
diagnosis of diabetes. In 1998 all risk factors, with the exception of age, were analyzed as 
categorical variables. 
25
 The predictability of the categorical FRS was compared to the 
FRS containing the continuous variables and the results showed that the more recent 
version maintained Anderson et al’s predicting power 
25
. The risk factors included in the 
age-adjusted analysis were: hypertension, total cholesterol, high density lipoprotein, 
smoking status, and diabetes diagnosis. 
ACLS Measurements 
Definition of Outcome 
 Coronary heart disease (CHD) was the primary endpoint being investigated. CHD 
was defined as the self-report of myocardial infarction or revascularization (including, 
bypass, coronary balloon, angioplasty, or stent) or death due to CHD. Deaths among 




Death Index. International Classification of Disease (ICD) codes: 410.0-414.0 (Ninth 
edition) and I20-I25 (Tenth edition), were used to identify CHD as the primary cause of 
death. In accordance with FRS’ follow-up time definition, the maximal follow up time 
was 12 years. The 12-year follow up was used in the regression and survival analysis and 
then adapted to provide a 10-year CHD incidence estimates. 
Derivation of Covariates 
 The covariates considered for analysis in the ACLS population mimicked the 
variables included in the recently-updated Framingham Risk Score. Hypertension (HTN) 
was defined through the categorization of systolic blood pressure and diastolic blood 
pressure. Systolic blood pressure was categorized in to five levels: <120 mm Hg, 120-129 
mm Hg, 130-139 mm Hg, 140-159 mm Hg, or ≥160 mm Hg. Diastolic blood pressure 
was categorized in to five levels: <80 mm Hg, 80-84 mm Hg, 85-89 mm Hg, 90-99 mm 
Hg, ≥ 100 mm Hg. When an individual’s blood pressure fell into different categories for 
systolic and diastolic blood pressure, the higher category was chosen for categorization. 
(For example, if a participant’s blood pressure was 130/80 (SBP/DBP), the corresponding 
categories for systolic blood pressure would be 2, and the diastolic blood pressure 
category would be 1. To determine the HTN category, the highest classification would be 
chosen, in this example the HTN categorization would be 2.) HTN definition was made 
without regard to a participant’s use for antihypertensive medication. The definition of 
HTN parallels FRS’ definition. 
22,25
 
Total cholesterol was grouped in to four levels: <200 mg/dL, 200-239 mg/dL, 
240-279 mg/dL, and ≥ 280 mg/dL. High density lipoproteins were categorized as: <35 




an individual as having diabetes. Smoking status was dichotomized as current or non-
smoker. All categorizations and definitions were analogous to FRS’ covariate groupings. 
25
 
The volume of participant-level measurements is rare and unusual in a large, 
single center epidemiological study. The major assessment variables cover a range of 
clinical and physical examination data, although limitations are still apparent. One 
limitation of ACLS’ measurements is the lack of nutritional and dietary measures. A 
second limitation is the absence of participant’s medication information. Despite these 
limitations, the analyses employed for this research do not require either piece of data. 
The ACLS study protocol was annually reviewed and approved by the Cooper 
Institute Institutional Review Board.  
 
 
PAPER 1: Framingham Risk Score applied to the Aerobic Center Longitudinal 
Study (ACLS) 
Purpose 
This manuscript will address Hypothesis 1: the Framingham Risk Score will be a 
significant predictor of CHD events for men within the ACLS population. 
Study Design  
 Analysis were performed using the ACLS prospective cohort. Predictor variables 
were determined at baseline examination and each participant and follow-up was 






 Men who completed a baseline examination at the Cooper Clinic in Dallas, TX 
between 1970 and 2003 and were free of CHD were included in the study population. 
Participants were volunteers and consented to follow up examinations prior to baseline 
exam. The exclusion criteria initially applied omitted individuals age less than 30 years or 
older than 75, with a body mass index less than 18.5kg/m
2
, a history of CHD, stroke, or 
cancer at baseline, and follow-up time less than one year. Individuals needed complete 
data on all variables of interest: systolic and diastolic blood pressure, cigarette smoking, 
cholesterol levels, diabetes diagnosis, and electrocardiogram. Participants must have 
completed a baseline examination between 1970 and 2003 and all participants were 
followed until death or 31 December 2003. Men comprised 76% (n=34,557) of the study 
population (n=45,833). Women were excluded from analysis due to the small number of 
CHD events (n=45) among this subgroup. The average age for men was 44 years. The 
majority of participants were Non-Hispanic, white, and well-educated. The Cooper 





Figure 3.1. Study flow for Paper 1 and Aerobic Center 
Longitudinal Study (ACLS) inclusion criteria depicting 
final sample size and coronary heart disease (CHD) 
event frequency. Men with complete Framingham Risk 
Score (FRS) data and body mass index (BMI) ≥ 18.5 
kg/m
2
 were included in the analysis. 
 
Measures 
 Measurements from the ACLS cohort involved in this analysis were previously 
described in detail at the beginning of Chapter III. The following is an overview of the 
variables used to investigate Hypothesis I. 
Definition of Outcome 
 The outcome of interest was coronary heart disease (CHD). This event was 
defined as the self-report of myocardial infarction or revascularization (including, bypass, 
coronary balloon, angioplasty, or stent) at a return clinic visit or on a mail-back 
questionnaire; or death due to CHD. The time to follow-up began at the baseline 
examination and continued until CHD event or 1 July 2004. Deaths among study 




Death Index. International Classification of Disease (ICD) codes: 410.0-414.0 and I20-
I25, were used to identify CHD as the primary cause of death. In accordance with FRS 
follow-up time definition, the maximal follow up time was 12 years. 
Predictor Variables 
 The covariates considered for analysis in the ACLS population mimicked the 
variables included in the Framingham Risk Score. Age was defined as a continuous 
variable. Hypertension (HTN) was defined through the categorization of systolic blood 
pressure and diastolic blood pressure. Systolic and diastolic blood pressure were 
categorized in to five levels. When an individual’s blood pressure fell in to different 
categories for systolic and diastolic blood pressure, the higher category was chosen for 
categorization. HTN definition was made without regard to a participant’s use for 
antihypertensive medication. The definition of HTN parallels FRS’ definition that 
utilized the measured systolic and diastolic blood pressure. 
22,25
 
Total cholesterol and high density lipoprotein measures were grouped in to four 
levels. : <200 mg/dL, 200-239 mg/dL, 240-279 mg/dL, and ≥ 280 mg/dL. High density 
lipoproteins were categorized as: <35 mg/dL, 35-59 mg/dL, and ≥ 60 mg/dL. A 12-hour 
fasting glucose >140 mg/dL classified an individual as having diabetes. Smoking status 
was dichotomized as current or non-smoker. All categorizations and definitions were 




 Descriptive statistics were generated to compare the ACLS population to the 
Framingham Heart Study population. The variables compared for the male populations of 




and HDL, percent diabetic, and percent whom are current smokers. Univariate Cox 
Proportional Hazard models were performed for the outcome of interest and each 
covariate to determine each characteristic’s prediction power.  Survival analyses were 
conducted to determine the 5 and 10 year CHD risk for the ACLS male population. The 
full, age-adjusted survival model contained the outcome and all covariates.  Statistical 
tests were two sided and a p-value<0.05 signified statistical significance.   
 Predictive accuracy for both models, 10 and 20-year CHD risk, was determined 
through the concordance-statistic (c statistic) associated with the receiver operating 
characteristic (ROC) curve. The ROC curve estimates the concordance probability 
between the observed and expected number of CHD events. The Hosmer-Lemeshow 
statistic is used to assess calibration and is a chi-square test by sorting the sample by 
estimated probability of success. 
169
 A limitation of the Hosmer-Lemeshow test is that it 
is not recommended for sample sizes larger than 25,000. A sensitivity analysis was 
performed following Paul et al’s (2013) recommendations and the ACLS sample 
(n=34,557) was randomly divided in to two equal groups. The c-statistic from the 
randomly divided sample cohorts and the full cohort were compared and no significant 
statistical difference was found. All analyses were performed with the statistical software, 





PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic 
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness 
(CRF) 
Purpose 
This manuscript will address Hypothesis 2: the CRF variable will significantly 
improve the Framingham Risk Score predictive ability of CHD events for men within the 
ACLS population. 
Study Design 
 Survival analysis and predictive modeling was performed using the ACLS 
prospective cohort. Predictor variables were determined at baseline examination and each 
participant and follow-up was conducted to ascertain information on the occurrence (or 
non-occurrence) of a CHD event. 
Study Population 
 The current analyses include men from the Cooper Clinic who completed a 
baseline medical exam between 1970 and 2003. Participants between the ages of 30-74 
were included in the analysis. Participants were excluded if they reported a history of 
CHD, stroke, or cancer at baseline or did not have data available on systolic and diastolic 
blood pressure, cigarette smoking, cholesterol levels, diabetes diagnosis, and 
electrocardiogram. Participants were patients of the Cooper Clinic and asked to 
participate in ACLS. Individuals were only included if they achieved ≥85% age-predicted 
maximal heart rate at each visit. Participants were primarily from the middle to upper 
socioeconomic group and had a median age of 44 years.  The Institutional Review Board 





 Figure 3.2. Study flow for Paper 2 and Aerobic Center 
Longitudinal Study (ACLS) inclusion criteria depicting 
final sample size and coronary heart disease (CHD) 
event frequency. Men with complete Framingham Risk 
Score (FRS) data and body mass index (BMI) ≥ 18.5 
kg/m
2
 were included in the analysis. 
 
Measures 
 Measurements from the ACLS cohort involved in this analysis were previously 
described in detail at the beginning of Chapter III. The following is an overview of the 
variables used to investigate Hypothesis II. 
Definition of Outcome 
 Coronary heart disease (CHD) was defined as the self-report of myocardial 
infarction or revascularization (including, bypass, coronary balloon, angioplasty, or stent) 
at a return clinic visit or on a mail-back questionnaire; or death due to CHD. The time to 




2004. Deaths among study participants were identified from the National Center for 
Health Statistic’s National Death Index using ICD codes: I11 and I20-I25 that identify 
CHD as the primary cause of death. In concordance with FRS follow-up time definition, 
the maximal follow up time was 12 years. The risk of CHD was tested for a 5-year and 
10-year follow up. 
Predictor Variables 
 The measures utilized to test Hypothesis 2 are inclusive of the covariates 
described to test Hypothesis 1, with the addition of cardiorespiratory fitness (CRF). In 
brief, the objectively measured predictor variables included in the analysis were a five 
level categorical variable for hypertension defined through systolic and diastolic blood 
pressure, five levels of total cholesterol, high density lipoprotein categorized in five 
different groups, diagnosis of diabetes defined as either yes or, and dichotomized current 
smoking status. Age was included as a continuous variable. This version of FRS 
25
 
incorporated categorical variables for age, hypertension, total cholesterol, HDL-C, 
smoking, and diabetes to determine a point value that could be summed and interpreted 
as an overall 10-year risk for CHD. The FRS was applied to every individual, and men 
were stratified based on their level of 10-year CHD risk. A point summation ≤5 points 
was classified as ‘low’ risk and a point summation >5 points was categorized as 
‘moderate or high’ risk for CHD. 
The main predictor variable of interest was cardiorespiratory fitness (CRF). A 
maximal exercise test was performed to determine each participant’s CRF. The 
technicians administered the Balke protocol for maximal exercise test while encouraging 




indicator of aerobic power. CRF is a gender-specific, age-adjusted Metabolic Equivalent 
of Task (MET) value at the final grade and speed of the treadmill test. One MET is equal 




 Descriptive statistics were generated to analyze the population’s representation 
among the predictor variables. Univariate survival models were performed for CHD 
event and each covariate to determine each characteristic’s prediction power.  Men with 
and without incident CHD were compared on mean age, mean fitness defined through 
maximally achieved METs, proportion of men with low, moderate, or high CRF, the 
average FRS point summation, proportion of men with ‘moderate or high’ 10-year CHD 
risk, hypertension classification, cholesterol levels, diabetes diagnosis, and smoking 
status. To determine each of the aforementioned covariate’s association with CHD 
events, univariate survival analysis was performed. Cox Proportional Hazard Models, 
adjusted for baseline examination year, also were fit to determine the association between 
CRF and CHD events while controlling for 10-year CHD risk. To test for an interaction 
between CRF and FRS, survival analysis was performed on a population stratified by 
‘low’ and ‘moderate or high’ 10-year CHD risk, while adjusting for age and baseline 
examination year. SAS
®






PAPER 3: Determine the association between non-exercise estimated 
Cardiorespiratory Fitness (e-CRF) and Coronary Heart Disease. Utilize e-CRF and 
Framingham Risk Score (FRS) to predict the risk of CHD. 
Purpose 
This manuscript will address Hypothesis 3: the e-CRF will be significantly 
protective against CHD. We also hypothesize that e-CRF and FRS will have a significant 
association with CHD. 
Study Design 
 Survival analysis and predictive modeling was performed using the ACLS 
prospective cohort. Predictor variables were determined at baseline examination and each 
participant and follow-up was conducted to ascertain information on the occurrence (or 
non-occurrence) of a CHD event. 
Study Population 
 Patients of the Cooper Clinic in Dallas, TX who consented to participation in the 
ACLS cohort are considered for inclusion in the analysis. To be included in the following 
analysis, participants had to complete their baseline examination between 1979 and 2002 
and have at least one year of follow up. Only men were considered in this analysis 
because of the low number of CHD events in women in the ACLS. Individuals were 
between the age of 30-74 with a BMI higher than 18.5 kg/m
2
. Only individuals with 
complete information on all the possible covariates were included in the analysis. 
The majority of participants were Non-Hispanic, White, with a median age of 44 




socioeconomic group. The Cooper Clinic’s Institutional Review Board annually reviewed 
and approved ACLS’ protocol.  
 Figure 3.3. Study flow for Paper 3 and Aerobic Center 
Longitudinal Study (ACLS) inclusion criteria depicting 
final sample size and coronary heart disease (CHD) 
event frequency. Men with complete Framingham Risk 
Score (FRS) data and body mass index (BMI) ≥ 18.5 
kg/m
2
 were included in the analysis. 
 
Measures 
 Measurements from the ACLS cohort involved in this analysis were previously 
described in detail at the beginning of Chapter III. The following is an overview of the 
variables used to investigate Hypothesis III. 
Definition of Outcome 
 Coronary heart disease (CHD) was the outcome of interest for the proceeding 
analyses. CHD was recorded if there was a presence of self-reported myocardial 




stent), or death due to CHD. Follow up was measured at the baseline examination and 
continued until occurrence of CHD event or 1 July 2004. Deaths among study 
participants were identified from the National Center for Health Statistic’s National 
Death Index through December 31, 2003. In concordance with FRS follow-up time 
definition, the maximal follow up time was 12 years. 
Predictor Variables 
 The variables considered in the age-adjusted reduced model for Hypothesis 3 are 
estimated MET values for CRF, systolic and diastolic blood pressure classified as a five 
level hypertension variable, objectively measured cholesterol levels: total cholesterol and 
high density lipoprotein, diabetes diagnosis assessed through a 12-hour fasting glucose, 
and a self-report current smoking status. A composite score was derived from FRS and 
point values were tabulated for each participant based on Wilson et al’s study 
113
 and the 
cohort was stratified based on their ‘low’ or ‘moderate or high’ 10-year CHD risk. A 
point summation > 5 points was considered ‘moderate or high’ risk.  A non-exercise 
predictor variable of CRF based on the prediction modeling of Jurca et al (2005) 
170
 will 
replace CRF that was measured by a maximal exercise test.  
 Estimated CRF (e-CRF) is a non-exercise estimation of CRF generated from a 6-
item, non-exercise, scale estimating CRF (e-CRF) 
171
 was recently developed and 
incorporates age, body mass index (BMI), waist circumference, resting heart rate, 
smoking status, and physical activity. Physical activity was captured through a medical 
history questionnaire where participants reported their regular physical activity for the 
past 3 months. 
41,172
 Physical activity was then dichotomized in to two levels: none or 




was determine by computing the random intercept’s square root of the sum and the 
residual variances. 
171,173
  Estimated CRF (e-CRF) was expressed in metabolic equivalent 
of task (MET) units. METs were estimated using a 6-item questionnaire 
170,174
. The sex-
specific questionnaire is composed of a participant’s age, BMI, waist circumference 
(WC), resting heart rate (RHR), two-level physical activity (activity), and smoking status 
(smoke). These variables are applied to Jackson et al’s algorithm 
171
 below.  
              (          )  (           )  (          )
 (         )  (          )  (             )  (     
       ) 
The estimated METs were categorized into three age-adjusted e-CRF tertiles: low, 





Descriptive statistics were calculated for the total study population and stratified 
by e-CRF. Chi-square tests were conducted to determine significant differences between 
the e-CRF levels and each risk factor. Death rate per 10,000 person-years for follow-up 
was calculated for e-CRF and 10-year CHD Risk. Crude Cox Proportional Hazard 
Models, adjusting for baseline examination year, were generated to determine the 
association between e-CRF and CHD, and the relationship between 10-year CHD risk 
and CHD. A fully adjusted Cox Proportional Hazard Model was used to determine the 
relationship between e-CRF, 10-year CHD risk and CHD. The effect of e-CRF on CHD 




status, and diabetes diagnosis. To investigate if there was a significant interaction 
between e-CRF and 10-year CHD risk, the male ACLS participants were stratified by 
‘low’ or ‘moderate or high’ CHD risk and hazard ratios between e-CRF and CHD were 
calculated. The receiver operating characteristic (ROC) curves were plotted to determine 
if there was a significant improvement in the predictive accuracy of CHD by augmenting 
the FRS point summation with e-CRF. The chi-square test determined if there was a 
significant difference between the models. The Hosmer-Lemeshow statistics was used to 
asses calibration and goodness of fit; the statistics compares the predictive and observed 
events but is limited to sample sizes smaller than 10,000 observations. 
169
 To control for 
this limitation, a random sample population was generated from the larger study 
population to perform this goodness of fit test. SAS
®
 version 9.3 was used to perform all 
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Coronary heart disease (CHD) remains a leading cause of death in the United States. The 
Framingham Risk Score (FRS) was developed to help clinicians in determining their 
patients’ CHD risk. We hypothesize that the FRS will be significantly predictive of CHD 
events in men within the Aerobics Center Longitudinal Study (ACLS) population. 
Methods 
The study included 34,557 men who attended the Cooper Clinic in Dallas, TX for a 
baseline clinical exam between 1970 and 2003. CHD events included self-reported 
myocardial infarction or revascularization, or death due to CHD. There were 587 CHD 
events during the 12-year follow-up. Multivariable-adjusted hazard ratios generated from 
ACLS analysis were compared to the FRS’ application to the Framingham Heart Study 
(FHS).  
Results 
The ACLS cohort produced similar hazard ratios to the FHS. The adjusted Cox 
proportional hazard model revealed men with total cholesterol of ≥280mg/dL were 2.21 
(95% Confidence Interval (CI) 1.59, 3.09) times more likely to have a CHD event 
compared to men with total cholesterol between 160-199mg/dL; men with diabetes were 
1.63 (95% CI 1.35, 1.98) times more likely to experience a CHD event compared to men 
without diabetes. 
Conclusion 
The FRS significantly predicts CHD events in the ACLS cohort. To the best of our 
knowledge, this is the first report of a large, single-center cohort study to validate the 





Coronary heart disease (CHD) remains one of the leading causes of death in the 
United States, accounting for approximately 17% of the overall national health care 
expenditures. 
3
 CHD is the accrual of plaque in the arteries of the heart 
6
 that supply the 
blood for maintaining normal cardiac function. The accumulation of plaque narrows the 
heart’s arteries and reduces blood flow to the heart muscle. The lack of oxygen-rich 
blood to portions of the heart muscle leads to ischemia of myocardial tissues and 
consequent alteration of heart function. CHD also can be caused by the deposition of fat 
beneath the endothelium, reducing the elasticity of arteries. 
6
  This arterial damage has 







 and smoking. 
11
 However, because these risk factors 
are modifiable through individual and population-level behavior change, medical 
prevention through closely monitoring cholesterol, blood glucose, and other risk factors, 
and treating any of these risk factors that are above acceptable ranges with medication 
such as statins or insulin, many countries have experienced a decrease of CHD incidence 
in the past 30 years. 
8
   
Several risk scores have been developed to provide guidance to clinicians on their 
patients’ risk for CHD. 
18,23
 The Framingham Risk Score (FRS) 
23,25
 is the CHD risk 
score most widely utilized by clinicians across the globe. 
24
 The FRS originated from the 
Framingham Heart Study (FHS), a relatively homogeneous cohort residing in 
Framingham, Massachusetts, 
23
 and has been applied and validated in a variety of 
different populations. 
26,114
 However, Kagan et al’s 
26
 study lacked complete congruency 
with FRS methodology and other studies such as Lee et al’s 
114






relatively small sample sizes. A recent publication updated the 1998 FRS and developed 
a new risk score that predicted an individual’s cardiovascular disease risk, instead of the 
CHD outcome. 
176
 For the purposes of this study, we have chosen to investigate CHD 
outcomes as they comprise the majority of CVD events. 
177
 
The current research aims to expand on the recent validation studies 
28
 employing 
the Aerobics Center Longitudinal Study (ACLS) cohort and the measured outcome of 10-
year risk for CHD. ACLS provides a larger cohort to validate FRS compared to FHS or 
previous studies and FRS has yet to be applied to this cohort. This cohort includes 
extensive measures of FRS components and CHD outcomes on more than 40,000 
participants. 
43
 We hypothesize that the FRS will be significantly predictive of CHD 
events for men within the ACLS population.  
 
Methods 
Study Population  
ACLS is an observational longitudinal study whose members were patients of the 
Cooper Clinic, Dallas, TX, where they received a preventive medical examination and 
counseling on health behaviors during periodic visits. The Cooper Clinic serves anyone 
who elects to come for an examination and patients come from all 50 states.  During the 
patients’ medical examination, they were informed of the ACLS, asked to participate, 
and, if they agreed to participate, consented to follow-up surveillance. The ACLS 
protocol was annually reviewed and approved by the Cooper Institute Institutional 




The participants were examined at least once during 1970 and 2003 at the Cooper 
Clinic. The cohort consists mostly of individuals within the middle and upper 
socioeconomic groups, with approximately 80% holding college degrees. 
41
 The mean 
baseline age of the cohort was 42 years 
34
 and consisted mostly of men (75%) and non-
Hispanic Whites (>95%).  
Although ACLS is not a representative sample of the entire US population, a 
comparison of median values of specific physiological variables show similarity to 
representative population data 
164
. A large number of women were enrolled in ACLS 
(n=11,276), however, women were excluded from this analysis due to the small number 
of CHD events (n=45) during the follow-up period. The following inclusion criteria were 
applied to the ACLS cohort for the current study: 1) Age at baseline examination between 
30-74 years; 2) Complete data for outcome and predictor variables; and 3) Free of CHD 
diagnosis or cancer diagnosis at baseline. To control for any unmeasured confounders 
that may have caused early drop-out, men with less than one year of follow-up were 




Trained technicians followed standardized protocols while conducting each 
measurement. The baseline clinical exam included a personal and family medical history, 
anthropometric measurements, a 12-hour fasting blood chemistry including glucose and 








Definition of Outcome 
CHD was the primary endpoint being investigated. CHD was defined as the self-
report of myocardial infarction or revascularization (including, bypass, coronary balloon, 
angioplasty, or stent), or death due to CHD. Participants reported their history of 
infarction or revascularization and incident date through a mail-back questionnaire 
administered in 1982, 1986, 1990, 1995, 1999, and 2004. Deaths among study 
participants were identified from the National Center for Health Statistic’s National 
Death Index. International Classification of Disease (ICD), Ninth and Tenth Revisions, 
codes: 410.0-414.0 and I20-I25, respectively, were used to identify CHD as the primary 
cause of death. According to FRS’ follow-up time definition, the maximal follow up time 
was 12 years. The 12-year follow up was used in the regression and survival analysis and 
then adapted to provide a 10-year CHD incidence estimates. 
 
Predictor Variables 
The covariates considered for analyses in the ACLS population mimicked the 
variables included in the recently-updated Framingham Risk Score. 
25
 Hypertension 
(HTN) was divided into four categories according to systolic blood pressure and diastolic 
blood pressure. Systolic blood pressure was categorized into four levels: <130 mm Hg, 
130-139 mm Hg, 140-159 mm Hg, or ≥160 mm Hg. Diastolic blood pressure was 
categorized into four levels: <85 mm Hg, 85-89 mm Hg, 90-99 mm Hg, and ≥ 100 mm 




diastolic blood pressure, the higher category was chosen for categorization. For example, 
if a participant’s blood pressure was 130/80 (SBP/DBP), the corresponding categories for 
systolic blood pressure would be 2, and the diastolic blood pressure category would be 1. 
To determine the HTN category, the higher classification would be chosen and the HTN 
categorization would be 2 in this example. HTN definition was made without regard to a 




Total cholesterol was grouped into four levels: <200 mg/dL, 200-239 mg/dL, 240-
279 mg/dL, and ≥ 280 mg/dL. High density lipoprotein was categorized as: <35 mg/dL, 
35-59 mg/dL, and ≥ 60 mg/dL. A 12-hour fasting glucose >140 mg/dL classified an 
individual as having diabetes. Smoking status was dichotomized as current or non-





Descriptive statistics were generated to compare the ACLS population to the 
Framingham Heart Study population. Males in each cohort were compared on mean age, 
percentage within each category in HTN, total cholesterol, and HDL, percent diabetic, 
and percent of current smokers. Univariate Cox Proportional Hazard models were 
performed for the CHD events and each covariate to determine each characteristic’s 
predictive power.  Cox Survival analyses were conducted to determine the 10-year CHD 




included age, blood pressure, total cholesterol, high density lipoprotein cholesterol, 
diabetes diagnosis, and smoking status.   
Predictive accuracy was determined through the concordance-statistic (c-statistic) 
associated with the receiver operating characteristic (ROC) curve. The ROC curve 
measures the discrimination power of these diagnostic markers for the CHD outcome. 
The Hosmer-Lemeshow statistic is used to assess calibration and is a chi-square test 
calculated by sorting the sample by estimated probability of success 
169
. The higher the c-
statistic the better the prediction.  A limitation of the Hosmer-Lemeshow test is that it is 
not recommended for sample sizes larger than 25,000. A sensitivity analysis was 
performed following Paul et al’s 
169
 recommendations and the ACLS sample (n=34,557) 
and a smaller 10,000 sample cohort was randomly selected. To satisfy this limitation, the 
Hosmer-Lemeshow test was performed on a randomly selected cohort (n=10,000) and a 
p-value>.05 represent no significant difference between predicted and observed events. 
All analyses were performed using SAS
®
 version 9.3 (SAS). 
 
Results 
During a 12-year follow- period (284,572 person-years of exposure), 587 men had 
a CHD event. The incidence rate was 20 per 10,000 person-years. The ACLS cohort had 
approximately 32,000 more participants (Table 4.1) compared to the Framingham Heart 
Study (FHS) and were, on average, younger (p<0.0001). FHS had a higher proportion of 
diabetics (5.0%) and smokers (40.0%) compared to the ACLS cohort of 1.5% and 17.0% 




When the ACLS cohort is stratified by CHD status, men who experienced a CHD 
event during the 12-year follow-up period were significantly different on all predictor 
variables; i.e. they were older, had higher blood pressure and were in the upper two 
categories for high-density lipoprotein cholesterol. Among those men who experienced 
CHD during follow-up, 4.6% were diabetic and 23.3% were smokers compared to 1.47% 
(p<0.001) and 16.8% (p<0.001) who did not experience CHD, respectively (Table 4.3). 
Table 4.3 displays the unadjusted and fully adjusted survival models. The 
covariates that were based on the FRS were all significant when applied to the men in 
ACLS. The hazard ratios reported from FHS by D’Agostino et al (2001)
28
  are similar to 
the ACLS fully adjusted hazard ratios. The fully adjusted HRs show men with Stage I 
HTN  (HR=1.41; 95%CI 1.16, 1.72) have significantly higher risk of CHD compared to 
men with optimal or normal blood pressure. Men with total cholesterol of ≥280mg/dL 
were more than twice (HR=2.21; 95% CI 1.59, 3.09) as likely to have a CHD event 
compared to men with total cholesterol between 160-199mg/dL Men with diabetes were 
1.82 (95% CI 1.23, 2.70) times more likely to experience a CHD event compared to men 
without diabetes. Smokers also experienced a significantly higher risk (HR=1.63; 95%CI 
1.35, 1.98) for CHD compared to past/nonsmokers during the 12-year follow-up. 
Figure 4.2 portrays the receiver operating characteristic (ROC) curve. The c-
statistic (Area Under the Curve) obtained from the ROC curve was 0.77 (95% CI 0.7523, 
0.7871). The Hosmer-Lemeshow test reported there was not a significant lack of fit for 
the model (p-value 0.88) and we failed to reject the null hypothesis that states there is no 






The FRS significantly predicts CHD events occurring during a 12-year follow-up 
in the Aerobics Center Longitudinal Study, which was a much larger study than the 
original Framingham Heart Study.  In addition to our main finding, age, blood pressure, 
total cholesterol, high density lipoprotein cholesterol, diabetes diagnosis, and smoking 
status were associated with CHD events. The relative risks were congruent with the those 
reported from the FHS 
28
 and previous literature. 
26,114
 
Elevated blood pressure creates more strain for the heart which can cause stiffness 
of the muscle 
6
 or create microscopic tears in the walls that may develop in to scar tissue 
6
. Myocardial ischemia is common in patients with hypertension 
16,74
 and reports from the 
FHS showed that hypertension was the primary cause of congestive heart failure in 35% 
of cases. 
77
 Diabetic men are also at increased risk for CHD 
83
 and additional research 
shows that individuals with both diabetes and .hypertension have a higher incidence of 
heart disease compared to people with diabetes or hypertension alone. 
16
 
Doyle et al published one of the first studies examining the association between 
smoking and CHD 
71
 in two prospective studies: The FHS and the Albany, New York 
Civil Servant study, with  a combined study population of over 1,800 men without CHD 
71
. The study concluded that men with elevated systolic blood pressure and total 
cholesterol who smoked were at a 1.8 (p<0.05) times higher risk of mortality compared to 
men with elevated systolic blood pressure and total cholesterol who did not smoke. 
71
 Our 
findings are also in line with The Physicians’ Health Study that reported significant 







Researchers have previously investigated FRS’ predictability in various 
populations. The Honolulu Heart Study was initiated in 1965 with the overall goal of 
standardizing cardiovascular examination. 
26
  The cohort is comprised of Japanese men 
born between 1900 and 1919 and updated with their World War II Selective Service 
Files; approximately 8,000 individuals free of CHD at study initiation, with a baseline 
examination constituted the final population
26
. Cigarette smoking, cholesterol levels, 
blood pressure, sum of skinfolds, and uric acid levels were significant predictors of CHD; 
however glucose intolerance showed no significant relationship. The lack of congruency 
in the significant results between the Honolulu Heart Study, FHS, and ACLS may be due 
to the Honolulu Heart Study population being at low risk of CHD (i.e. CHD incidence 
observed in the Honolulu Study was about half that of the FHS). 
To the best of our knowledge, this is the first large, single-center, prospective 
cohort to validate the FRS with the same level of precision as that in the FHS. The 
present study expands on previous research through the improvement of internal validity 
by utilizing objectively measured clinical data.  
Similar to FHS, a potential limitation of the ACLS cohort is the homogeneity of 
the study population’s sociodemographic factors. This limitation was explored through 
comparison analysis between ACLS and two large population-based cohorts and found 
that ACLS’ results were similar to the results of the Lipid Research Clinics Prevalence 
Survey and the Canada Fitness Survey. 
165
 It should be noted that ACLS’ homogeneity 
may be a strength through the improvement of internal validity by controlling for 
potential demographic confounders such as education, socioeconomic status, and 




should be conducted in more diverse populations. Unlike the FHS, stage II-IV 
hypertension was not significantly associated with CHD and may be due to the limitation 
in the small proportion (4.93%) of ACLS’ cohort was categorized in to this group. 
 
Conclusion 
Although CHD remains one of the leading causes of death in the United States, 
the prevalence of CHD has decreased since 2004;
4
 a reduction that can be largely 
attributed to better medical treatment and improvement in CHD risk profiles. The FRS 
was developed to assist clinicians in estimating their patients’ absolute risk for CHD. 
28
 
This study further evaluates FRS’ performance in the larger ACLS cohort, and strictly 
followed the FHS methodology which does not control for other CHD risk factors such 
self-rated health, 
141
 family history 
95
 of CHD, and cardiorespiratory fitness. 
43
  Future 
research should focus on the expansion of the FRS to include other modifiable risk 
factors. Community interventions and education programs should continue to target these 







Table 4.1. Comparison of Demographic Characteristics 
Between men free of coronary vascular disease at baseline 
the Framingham Heart Study (FHS) and the Aerobics 









 ACLS  
 
n=2,439 n=34,557 
Age, range (years) 30-74 30-74 
Mean age, y 48.30 44.82 
Blood Pressure, (mm HG) 
  
Optimal and Normal  
(S<130, D<85) 
44.00 59.85 
High Normal  
(S<140, D<90) 
20.00 16.24 
Stage I HTN  
(S<160, D<100) 
23.00 18.98 
Stage II-IV HTN 
 (S≥160, D≥100) 
13.00 4.93 
Total Cholesterol (mg/dL) 
  
<160 7.00 9.34 
160-199 31.00 34.36 
200-239 39.00 36.67 
240-279 17.00 15.10 
≥280 6.00 4.53 
HDL-C (mg/dL) 
  
<35 19.00 16.24 
35-59 70.00 70.97 
≥60 11.00 12.79 
Diabetes 5.00 1.52 
Current Smoking 40.00 16.95 
 
 
Abbreviations: CI; confidence interval; HTN, 








Independent t-test was used to determine statistically 
significant difference of age between FHS and ACLS; 
Proportion test calculated the statistical difference for 
each level of blood pressure, total cholesterol, HDL, 
diabetes, and current smoking between FHS and ACLS. 
All proportion tests were significant with a p-
value<0.001. 
c 
FHS, Framingham Risk Score descriptive statistics 







Table 4.2. Comparison in Demographic Characteristics Between Men With 









No CHD With CHD 
 
n=33,970 n=587 





Age, range (years) 30-74 30-73 
Mean age, y 44.70 51.91 
Blood Pressure, (mm HG) 
  
Optimal and Normal  
(S<130, D<85) 
60.06 47.53 
High Normal  
(S<140, D<90) 
16.18 19.76 
Stage I HTN  
(S<160, D<100) 
18.85 26.41 
Stage II-IV HTN 
 (S≥160, D≥100) 
4.90 6.30 
Total Cholesterol (mg/dL) 
  
<160 9.44 3.92 
160-199 34.62 19.59 
200-239 36.60 40.37 
240-279 14.88 27.60 
≥280 4.46 8.52 
HDL-C (mg/dL) 
  
<35 16.08 25.55 
35-59 71.05 66.44 
≥60 12.88 8.01 
Diabetes 1.47 4.60 
Current Smoking 16.84 23.34 
 
 




The numbers displayed are percentages unless otherwise stated
 
b 
Chi-square test was performed to calculate statistical difference 
between the group with and without CHD. All comparisons were 






Table 4.3. Hazard Ratios for coronary heart disease (CHD) Events for Framingham Heart Study 









HR 95% CI HR 95% CI HR 95% CI 
Age (years) 1.05 1.04 1.06 1.09 1.08 1.10 1.09 1.08 1.10 
Blood Pressure, mm HG       
Optimal and Normal  
(S<130, D<85) 
1.00 Referent 1.00 Referent 1.00 Referent 
High Normal 
 (S<140, D<90) 
1.31 0.98 1.76 1.66 1.33 2.06 1.33 1.07 1.66 
Stage I HTN  
(S<160, D<100) 
1.67 1.28 2.18 1.95 1.60 2.38 1.41 1.16 1.72 
Stage II-IV HTN 
 (S≥160, D≥100) 
1.84 1.37 2.06 1.94 1.37 2.73 1.23 0.87 1.74 
Total Cholesterol (mg/dL)          
<160 0.69 0.31 1.52 0.77 0.49 1.21 0.82 0.52 1.28 
160-199 1.00 Referent 1.00 Referent 1.00 Referent 
200-239 1.77 1.25 2.50 1.85 1.48 2.31 1.59 1.27 1.99 
240-279 2.10 1.43 3.10 2.90 2.28 3.68 2.37 1.86 3.01 
≥280 2.29 1.39 3.76 2.74 1.97 3.83 2.21 1.59 3.09 
HDL-C (mg/dL)          
<35 1.47 1.16 1.86 1.59 1.32 1.92 1.60 1.32 1.94 
35-59 1.00 Referent 1.00 Referent 1.00 Referent 
≥60 0.56 0.37 0.83 0.66 0.49 0.90 0.60 0.44 0.81 
Diabetes 1.50 1.06 2.13 3.45 2.34 5.07 1.82 1.23 2.70 
Smoking Status 1.68 1.37 2.06 1.60 1.32 1.93 1.63 1.35 1.98 
 
 









Framingham Heart Study hazard ratios from Wilson et al 1998 (10) 
b 
Fully adjusted model included age, blood pressure, total cholesterol, high density lipoprotein levels, diabetes 





















Figure 4.1. Study flow and Aerobic Center Longitudinal Study 
(ACLS) inclusion criteria depicting final sample size and 
coronary heart disease (CHD) event frequency. Men with 
complete Framingham Risk Score (FRS) data and body mass 
index (BMI) ≥ 18.5 kg/m
2












Figure 4.2.Receiver Operating Characteristic Curve representing the 
predictive ability of the Framingham Risk Score (FRS) applied to the 
ACLS cohort with a 12 year follow-up. The Hosmer-Lemeshow c-
statistic is represent by the Area Under the Curve (c=0.7697, 95% 




















The Framingham Risk Score (FRS) includes a limited set of risk factors and does 
not include cardiorespiratory fitness (CRF), which has been shown to have a strong 
protective effect on coronary heart disease (CHD). We aim to examine the association of 
CRF on 10-year risk of CHD while controlling for individuals’ FRS.   
Methods and Results 
The study included 29,854 men from the Aerobics Center Longitudinal Study 
(ACLS) who received a baseline examination from 1979 to 2002. CHD events included 
self-reported myocardial infarction or revascularization, or CHD death. Multivariable 
survival analysis investigated the association between CRF, FRS, and CHD. CRF was 
analyzed as both a continuous and categorical variable. The population was stratified by 
‘low’ and ‘moderate or high’ risk for CHD to test for interaction between CRF and FRS.  
Men with incident CHD were older (mean age = 51.6 years), had an average 
maximally achieved fitness of 10.9 metabolic equivalent of task (METs), and were more 
likely to have ‘moderate or high’ 10-year CHD risk, compared to men without incident 
CHD (p-value<0.001). CRF, defined as maximal METs, showed a 20% lower risk of 
CHD (HR=0.80, 95% CI 0.77, 0.83) for each 1 unit MET increase. Men within the ‘low’ 
10-year CHD risk strata and high (HR=0.62, 95% CI 0.45, 0.84) CRF had a lower CHD 
risk compared with men in the same strata, but with low CRF (p-value <0.001). 
Conclusion 
Clinicians should emphasize the promotion of physical activity to improve CRF to reduce 





The American Heart Association stated one of its 2020 Impact Goals was to reduce the 
deaths from cardiovascular disease (CVD) by 20%;
4
 coronary heart disease (CHD) 
comprised the majority of CVD deaths in 2006 and 2007.
177
 CHD is classified as plaque 
accumulation in the arteries of the heart, decreasing the supply of oxygen-rich blood.
177
 










CHD risk equations, such as the Framingham Risk Score (FRS), have been developed 
and employed to account for these and other risk factors .
23
 The FRS provides a sex-
specific, age-adjusted risk score that accounts for systolic and diastolic blood pressure, 
total cholesterol, high-density lipoprotein cholesterol (HDL-C), diabetes diagnosis, and 
smoking status.
25
 Previous studies 
29,30,104
 have modified the FRS to include additional 
risk factors. Tzoulaki et al 
104
 conducted a meta-analysis on 63 studies and examined how 
each study modified the FRS, including the addition of C-reactive protein,
29
 deletion of 
diabetes diagnosis,
30
 and alterations to blood pressure definitions.
178
 
None of these modifications involved the addition of cardiorespiratory fitness (CRF),  a 












 Barlow et al 
163
 showed that a 1-MET increase in CRF resulted in an 18% 
decrease in CVD mortality over a 30-year follow-up period in “low-risk” adults, as 
defined by the FRS. However, this result reflects control for additional factors besides 
CRF, such as body mass index (BMI) and early family history of CHD, which are not 




The aim of this study is to examine the association of CRF on 10-year risk of CHD while 
controlling for an individual’s FRS. Our secondary aim is to investigate if the relationship 




The Aerobics Center Longitudinal Study (ACLS) is a prospective cohort study involving 
a large group of men and women. The participants were patients of the Cooper Clinic, 
where they received a preventive medical examination and counseling on health 
behaviors during periodic visits. The participants were examined at least once from 1979 
to 2002 at the Cooper Clinic, Dallas, Texas. The protocol for ACLS was reviewed 
annually and approved by the Cooper Institute Institutional Review Board. Women were 
excluded from these analyses due to a small number of CHD events (n=45). Men were 
included based on the following criteria: 1) Age at baseline examination between 30-74 
years; 2) Complete data for outcome and predictor variables; and 3) Free of CVD or 
cancer diagnosis at baseline. A flow diagram of the study population is depicted in Figure 
5.1. 
Clinical Examination 
The baseline, clinical exam included an ECG, a 12-hour fasting blood chemistry analyses 
including cholesterol and glucose measurements, blood pressure assessment, and a 
maximal exercise test.
112,164,166






Definition of Outcomes 
CHD was defined through either self-report of revascularization (including, bypass, 
coronary balloon, angioplasty, or stent) or myocardial infarction (MI), or CHD specific 
mortality. A mail-back questionnaire was administered in 1982, 1986, 1990, 1995, 1999, 
and 2004 in which participants were asked to report their history of revascularization or 
MI along with the incident date. The National Center for Health Statistic’s National 
Death Index was used to identify CHD deaths in the ACLS cohort; International 
Classification of Disease (Ninth and Tenth Revisions) codes 410.0-414.0 were used to 
determine CHD as the primary cause of death. In accordance with FRS’s follow-up time 
definition, the maximal follow-up time for the ACLS study population was 12 years.  
 
Application of Framingham Risk Score 
FRS was derived from the Framingham Heart Study, which is an ongoing observational 
study initiated in 1948 and primarily recruits residents of Framingham, Massachusetts.
23
 
In a study published in 1998,
25
 the main outcome was a CHD event defined as a MI, 
coronary insufficiency, or CHD death. This version of FRS
25
 incorporated categorical 
variables for age, hypertension, total cholesterol, HDL-C, smoking, and diabetes to 
determine a point value that could be summed and interpreted as an overall 10-year risk 
for CHD. The FRS was applied to every individual, and men were stratified based on 
their level of 10-year CHD risk. A point summation ≤5 points was classified as ‘low’ risk 






The Balke maximal exercise treadmill test 
167
 was used to determine CRF, which was 
analyzed as a continuous and categorical variable. The continuous variable was the 
maximally achieved metabolic equivalent of task (MET). The following regression 
formula was employed to convert maximal treadmill time to METs :
48
 
     
(                               )       
   
 
Treadmill time converted to METs is analogous to peak VO2.
121
  
The categorical definition of CRF was based on a participant’s age-specific treadmill 
time from the entire ACLS cohort and consisted of three levels: “low (least fit 20%)”, 
“moderate (next fit 40%)”, and “high (most fit 40%)”.    
 
Statistical Analysis 
Descriptive statistics were computed for the total ACLS male population and stratified by 
incidence of CHD. Men with and without incident CHD were compared on mean age, 
mean fitness defined through maximally achieved METs, proportion of men with low, 
moderate, or high CRF, the average FRS point summation, proportion of men with 
‘moderate or high’ 10-year CHD risk, hypertension classification, cholesterol levels, 
diabetes diagnosis, and smoking status. To determine each of the aforementioned 




Cox Proportional Hazard Models, adjusted for baseline examination year, also were fit to 
determine the association between CRF and CHD events while controlling for 10-year 
CHD risk. To test for an interaction between CRF and FRS, survival analysis was 
performed on a population stratified by ‘low’ and ‘moderate or high’ 10-year CHD risk, 
while adjusting for age and baseline examination year. SAS
®
 version 9.3 (SAS) was used 
to perform all analyses.  
 
Results 
During a 12-year follow-up period (248,890 person-years of exposure), there were 499 
incident CHD events. This ACLS cohort used the FRS on approximately 30,000 men 
(Table 1). At baseline, the males in the overall ACLS cohort had an average age of 44.7 
years, 60.6% had either optimal or normal blood pressure, 4.7% had stage II-IV 
hypertension, 1.4% had diabetes, and 16. 6% reported being current smokers. Men with 
incident CHD were older, had higher prevalence of stage I hypertension, a lower HDL-C 
<35 mg/dL, a lower mean fitness, and were more likely to have ‘moderate or high’ 10-
year CHD risk, compared to men without incident CHD (p-value <0.0001 for all stated 
comparisons).   
Table 2 reports the univariate analyses between the risk factors that comprise the FRS 
and the risk for CHD. Men with optimal blood pressure were 33% less likely to 
experience a CHD event compared to men with normal blood pressure (HR=0.67, 95% 
CI 0.52, 0.87), while men with stage I hypertension were at a significantly higher risk 




significantly lower risk for CHD compared to men with HDL-C 45-49 mg/dL. Men 
diagnosed with diabetes and current smokers also were at a significantly higher risk for 
CHD compared to non-diabetics and non-smokers. For every FRS point increase, the 
relative risk for a CHD event increased 36% (HR=1.36 95% CI 1.32, 1.40). Similarly, 
men with a ‘moderate or high’ 10-year CHD risk had an almost 6-fold (HR=5.66 95% CI 
4.25, 7.55) higher risk for CHD compared to men with a ‘low’ 10-year CHD risk. A 
univariate analysis showed an inverse association between CRF and CHD. CRF, defined 
as maximal METs showed a 20% lower CHD risk (HR=0.80, 95% CI 0.77, 0.83) for 
each 1 MET increase. CRF also was categorized into low, moderate, and high and men 
with high CRF had 33% (HR=0.67, 95% CI 0.51, 0.88) lower risk for CHD compared 
with men who had low CRF (Table 3). Table 3 also reports the various survival models 
fit to test the association between FRS point, CRF, and risk of CHD. Model four reports 
the maximal METs protective effect on CHD (HR=0.82) while controlling for ‘moderate 
or higher’ 10-year CHD risk. Model 5 evaluates a similar association, but defines CRF as 
a categorical variable and shows that men with high CRF have 26% lower CHD risk 
while controlling for ‘moderate or high’ 10-year CHD risk. 
Figure 2 shows the association between CRF, FRS, and risk of CHD through 
stratification of the population by low and ‘moderate or high’ 10-year CHD risk. 
Compared with men in the same strata with low CRF there was a significant inverse trend 
among men within the ‘low’10-year CHD risk strata; Men with moderate (HR=0.92 95% 
CI 0.68, 1.25) and high (HR=0.62, 95% CI 0.45, 0.84) CRF had a lower probability of 
experiencing CHD (Ptrend <0.001). These associations were similar for men with 





Both FRS and CRF were strong independent predictors of CHD. CRF had a significant 
protective effect on CHD in men, after controlling for 10-year CHD risk based on the 
FRS point summation. When men were stratified by ‘low’ and ‘moderate or high’ 10-
year CHD risk, CRF’s protective effect became more apparent, with a significant inverse 
trend in low-risk adults. To our knowledge, this is the first study to investigate the 
association between CRF and CHD in males with ‘low’ and ‘moderate or high’ 10-year 
CHD risk. 
The FRS is comprised of CHD risk factors such as hypertension, cholesterol levels, 
diabetes diagnosis, and smoking.
25
 Various versions 
22,25,26,176
 that have included these 
risk factors repeatedly have shown the predictive power of the FRS. 
179
 Myocardial 
ischemia is common in patients with hypertension;
16,74,75
 although a recent study reported 
a 1.4 mm Hg decrease in mean systolic blood pressure from 1994 to 2005 that could be 
associated with a 20% reduction in CHD deaths.
9
 A diabetes diagnosis also previously 
has been shown to significantly increase a person’s risk for CHD.
83,84
 Diabetes can cause 
impairment in the cardiac muscle that may lead to cardiomyopathy, congestive heart 
failure, or ischemic heart disease and can increase the 5-year mortality rate after a 
myocardial infarction.
16
  Doyle et al published one of the first studies examining the 
association between smoking and CHD.
71
 That study concluded that while problems with 
blood pressure and cholesterol were absent, participants who reported being smokers 
were at a significantly higher risk for CHD mortality compared to nonsmokers.
71
 
Our finding that CRF has a significant protective effect on CHD is similar to findings 
previously reported in the literature.
34,43,46,87




between CRF and CHD in asymptomatic men and found during a nine year follow-up the 
more fit men had the least CHD risk compared to the fourth quartile.
45
 Lee et al built on 
these findings by analyzing CRF’s association with CVD while controlling for body 
composition. That study reported that lean, unfit men had three times higher risk of dying 
from CVD (RR=3.16, 95% CI 1.12, 8.92) compared to lean, fit men.
46
  Improved CRF 
may reduce CHD risk through improved muscle mass 
152,153
 and enhancement in arterial 
oxygen content.
180
  Research has shown that CRF can increase the double-product 
threshold for ischemic ST-segment depression,
154,155
 a decrease in the magnitude of ST 
depression, and a diminished maximal ST depression.
154
 CRF also may have a positive 
effect on coagulation 
156,157




Our findings regarding the association between CRF, FRS, and risk for CHD are 
consistent with recent findings. Barlow et al 
163
 investigated the association of CRF and 
CVD mortality in men and women that were at low risk for CHD events. The study 
concluded that a 1-MET increase in CRF resulted in an 18% decrease in CVD mortality 
during a 30 year follow up period.
163
 Gupta et al 
50
 utilized the ACLS cohort with data 
ranging from 1970 through 2006 and employed a traditional CHD risk factor model that 
adjusts for age, systolic blood pressure, diabetes, total cholesterol, and smoking status 
and reported that CRF augmented CHD risk factor model correctly reclassified 
participants with CHD death based on their 10-year risk,
50





The current study builds on the aforementioned research by applying the FRS to a large, 
single-center, longitudinal cohort with the same level of precision as the Framingham 
Heart Study that generated the FRS. The previous studies either modified the outcome of 
interest or the predictor variables included in the risk score. The American College of 
Cardiology and the American Heart Association recently developed the Pooled Cohort 
Equation for estimating artherosclerotic cardiovascular disease (ASCVD) 
181
 that 
encompassess similar risk factors as FRS but offers risk estimates for myocardial 
infarction, CHD death, stroke, and stroke death. This project decided to focus on 
prevoiusly defined CHD that includes angioplasty and revascularization while excluding 
stroke and stroke death. Future research should investigate the potential effect the Pooled 
Cohort Equation may have on ASCVD with the addition of CRF. 
To the best of our knowledge, this is the first prospective cohort to investigate CRF’s 
associations with 10-year risk of CHD while controlling for the FRS 
25
 in its entirety. A 
possible limitation to the current study is the homogeneity of the ACLS population. At 
the time of enrollment, ACLS consisted of mostly men, mean age 42 years , and was 
predominantly non-Hispanic Whites (>95%). However, a comparison study between 
ACLS and two large population-based cohorts found ACLS’s results were similar to that 
of those cohorts.
165
  It also should be noted that ACLS’ homogeneity improves internal 
validity by controlling potential confounders such as socioeconomic status and education, 






Our study found that CRF and FRS are both significant predictors of CHD events. 
Moderate and high fit men have lower risk for CHD compared to men with low CRF; this 
association remains significant when the population was stratified into ‘low’ and 
‘moderate or high’ risk for CHD. It may be advantageous for clinicians to evaluate a 
patient’s CRF to provide a more accurate assessment of the 10-year risk for CHD. CRF is 
a modifiable predictor of CHD and improved CRF may lead to an improvement in the 
FRS and 10-year CHD risk, as well as an improvement in the ability to predict long-term 
CHD risk. Clinicians should vigorously promote exercise therapy and increases in 
physical activity to their patients in efforts to increase CRF in the long-term prevention of 
CHD.
182,183
  Researchers should consider developing a randomized clinical trial to 
determine the effect that CRF changes may have on an individual’s FRS overall, the 








Table 5.1. Comparison of demographic characteristics between men 
(n=29,854) with incident coronary heart disease (CHD) and no incident 













n=29,854 n=499 n=29,355 
 
Age, range (years) 30-74 31-73 30-74 
 
Mean Age, y 44.72 51.57 44.60 <0.0001 
Mean Fitness,  
maximally achieved 
MET 
11.95 10.92 11.97 <0.0001 
Cardiorespiratory 
Fitness     
Low 11.58 13.43 11.54 0.19 
Moderate 38.45 43.29 38.37 0.03 
High 49.97 43.29 50.09 0.0029 
Mean FRS, points 3.51 6.15 3.47 <0.0001 
‘Moderate or High’ 
10year CHD risk  
2.05 10.42 1.91 <0.0001 
Blood Pressure, mm HG 
    
Optimal                                                 
(S<120, D<80) 
28.82 19.44 28.98 <0.0001 
Normal                                                           
(S<130, D<85) 
31.82 30.26 31.85 0.45 
High Normal                                           
(S<140, D<90) 
15.97 19.64 15.91 0.02 
Stage I HTN                                                             
(S<160, D<100) 
18.72 25.45 18.61 <0.0001 
Stage II-IV HTN               
(S≥160, D≥100) 
4.67 5.21 4.66 0.56 
Total Cholesterol, 
mg/dL     
<160 9.15 3.81 9.25 <0.0001 
160-169 34.11 19.24 34.36 <0.0001 
200-239 36.90 40.48 36.84 0.09 
240-279 15.30 27.25 15.10 <0.0001 
≥280 4.54 9.22 4.46 <0.0001 
HDL-C, mg/dL 
    
<35 15.60 25.25 15.43 <0.0001 




45-49 15.58 13.03 15.62 0.11 
50-59 21.42 15.83 21.52 0.0021 
≥60 13.28 7.21 13.38 <0.0001 
Diabetes 1.39 4.41 1.34 <0.0001 
Current Smoking 16.56 21.84 16.47 0.001 
Abbreviations: CHD, coronary heart disease; FRS, Framingham Risk Score; 
HDL-C, high density lipoprotein- cholesterol; HR, hazard ratio; MET, metabolic 
equivalent of task 
*Student t-test was used to calculate the difference between incident CHD and no 
incident CHD for age, mean fitness, and mean Framingham Risk Score points. 





Table 5.2. Univariate survival analyses between the Framingham Risk 




Model One, Univariate 
RISK FACTOR HR 95% CI 
Age 
1.09 1.08 1.10 
Blood Pressure, mm HG    
Optimal                                                 
(SBP<120, DBP<80) 
0.67 0.52 0.87 
Normal                                                           
(SBP <130, D<85) 
1.00 - - - - 
High Normal                                           
(SBP <140, DBP<90) 
1.36 1.06 1.76 
Stage I HTN                                                             
(SBP <160, DBP<100) 
1.55 1.23 1.97 
Stage II-IV HTN                
(SBP ≥160, DBP≥100) 
1.34 0.89 2.04 
Total Cholesterol, mg/dL 
   
<160 0.77 0.47 1.26 
160-169 1.00 - - - - 
200-239 1.87 1.47 2.38 
240-279 2.89 2.22 3.75 




   
<35 1.82 1.35 2.46 
35-44 1.33 1.01 1.76 
45-49 1.00 - - - - 
50-59 0.89 0.64 1.23 
≥60 0.64 0.43 0.96 
Diabetes 3.54 2.31 5.42 
Current Smoking 1.51 1.22 1.87 
 
Abbreviations: CI, confidence interval;  DBP, diastolic blood 
pressure; HDL-C, high density lipoprotein- cholesterol; HR, hazard 










Table 5.3. Model Building to assess the association between Framingham Risk Score (FRS) assessment, cardiorespiratory fitness 
(CRF), and coronary heart disease (CHD)   
 
Model I, 









RISK FACTOR HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
FRS, points 
1.36 1.32 1.40 1.34 1.29 1.39 1.36 1.32 1.41       
10 year CHD risk
||
 
   
            
Low Risk 
1.00 - - - -       1.00 - - - - 1.00 - - - - 
‘Moderate or 
High’ Risk 
5.66 4.25 7.55       3.50 2.59 4.73 5.38 4.03 7.19 
Maximally 
achieved  METs 
0.80 0.77 0.83 0.95 0.91 1.00    0.82 0.79 0.85    
Cardiorespiratory 
Fitness 
   
            
Low 1.00 - - - -    1.00 - - - -    1.00 - - - - 
Moderate 0.93 0.71 1.22    1.15 0.88 1.52     0.98 0.75 1.30 









Abbreviations: CI, confidence interval; CHD, coronary heart disease; HR, hazard ratio 
*
Model II investigates the association between maximal METs achieved and CHD events while controlling for FRS point 
summation and baseline examination year 
†
Model III investigates the association between CRF categorized in to low, moderate, and high fitness and CHD events 
while controlling for summation of FRS points and baseline examination year 
±
Model IV investigates the association between maximally achieved METs and CHD events while controlling for 
‘moderate or high’ 10 year CHD risk and baseline examination year 
§
Model V investigates the association between CRF categorized in to low, moderate, and high fitness and CHD events 
while controlling for ‘moderate or high’ 10 year CHD risk and baseline examination year 
||
Low and ‘‘moderate or high’’ 10 year CHD risk is a comparative risk calculated from the summation of FRS points. 











Figure 5.1. Study flow and Aerobic Center Longitudinal Study 
(ACLS) inclusion criteria depicting final sample size and 












Figure 5.2. Adjusted Hazard Ratios and 95% confidence intervals (95% CI) for the 
relationship between cardiorespiratory fitness (CRF) and 10-year coronary heart disease 
(CHD) risk stratified by ‘low’ and ‘moderate or high’ risk. A significant inverse 






Gander J, Sui X, Hébert JR, Hazlett LJ, Cai B, Lavie CJ, Blair SN. To be submitted to 





Addition of Estimated Cardiorespiratory Fitness to the Clinical Assessment of 10-










The Framingham Risk Score (FRS) was developed to quantify a patient’s CHD 
risk; although, many clinicians recognize its limitations. Cardiorespiratory fitness’ (CRF) 
is protective of CHD events, however the measurement is often not clinically viable.  
Non-exercise estimated CRF (e-CRF) is a practical alternative that was computed and 
tested in relation to the FRS and CHD. 
Methods 
Male participants (n=29,854) enrolled in the Aerobics Center Longitudinal Study 
(ACLS), completed a baseline examination between 1979-2002, and were followed for 
12 years to determine incident CHD defined either by self-report of myocardial infarction 
or revascularization, or CHD mortality. Estimated CRF was defined from a 6-item 
questionnaire and categorized using age-specific tertiles (low, middle, and high). 
Multivariable survival analysis determined the crude and adjusted association between 
FRS, e-CRF, and CHD. Interaction between e-CRF and FRS was tested by survival 
analysis on a population stratified by ‘low’ and ‘moderate or high’ 10-year CHD risk.  
Results 
Compared to men with low e-CRF, men with high e-CRF group was significantly 
(p-value < 0.0001) younger, had a higher proportion of optimal blood pressure, had a 
lower proportion of total cholesterol ≥ 240 mg/dL, and were less likely to be smokers. 
Unadjusted Cox analysis showed men with high e-CRF had a 36% (HR=0.64; 95% CI 
0.51, 0.80) CHD risk reduction compared to the men with low e-CRF (p-value for trend 




28% (HR=0.72; 95% CI 0.0.57, 0.91) less likely to experience an incident CHD event 
compared to men with low e-CRF.  
Discussion 
Among men with ‘low’ risk for CHD, those who were more fit had a decreased 
risk for CHD compared to men in the lowest third of fitness. Estimated CRF can add 




Despite the decrease in coronary heart disease (CHD) incidence worldwide in the 
past 30 years, 
7,8
 a decrease in age-adjusted CHD mortality in the United States (US), 
184
 
and decrease in self-reported CHD 
185
 from 2006-2010, CHD remains one of the leading 
causes of death in the U.S. 
186






 and smoking. 
11
 Risk scores have been developed to enable clinicians 
to quantify risk factors from their patients’ medical histories in order to provide an 




Sposito et al 
24
 reports from a cross-sectional survey among physicians that those 
utilizing CHD risk scores primarily chose to use the Framingham Risk Score (FRS) 
23
. 
The FRS was developed from the Framingham Heart Study (FHS) 
23
 and a 1998 version 
by Wilson et al 
113
 categorized the aforementioned risk factors to determine 10-year CHD 
risk and provide a score sheet for clinical implementation. The FRS’ predictive power has 
persisted through validation in various populations 
26,27




the inclusion of apolipoproteins, 
106
 C-reactive protein, 
29
 and involuntary job loss. 
30
  
Despite FRS’ strengths and predictive power, clinicians from Sposito et al’s analysis 





Similar to the FRS, cardiorespiratory fitness (CRF)’ protective effect on CHD 
45,46
 
and other adverse events has been well documented. 
34,43,88,127,141
 In a study with more 
than 22,000 men, a significant interaction between body composition and CRF reported 
that unfit lean men had a significantly three times higher risk for CHD mortality 
compared to fit lean men; unfit men with normal body composition had a 2.94 (95% CI 
1.48, 5.83) times higher risk compared to fit lean men. 
46
 CRF has traditionally been 
determined by an individual’s sex- and age-specific maximal oxygen uptake that is 
ascertained through a maximal exercise test. Due to the methodologic rigor and 
associated high costs, CRF has not been easily captured in clinical settings.  
 
Recently, a 6-item, non-exercise, scale estimating CRF (e-CRF) 
171
 was recently 
developed and incorporates age, body mass index (BMI), waist circumference, resting 
heart rate, smoking status, and physical activity. Physical activity was captured through a 
medical history questionnaire where participants reported their regular physical activity 
for the past 3 months. 
41,172
 Physical activity was then dichotomized in to two levels: none 
or low, and moderate or high physical activity. The accuracy of the developed algorithm 
was determine by computing the random intercept’s square root of the sum and the 
residual variances. 
171,173




investigated the association between e-CRF and CHD independently or in addition to a 
CHD risk score such as the FRS. This study was designed to expand on previous 
literature by determining the relationship between e-CRF and CHD. A second aim was to 
evaluate the potential for the e-CRF to add clinical value to the FRS by testing for 






 This study focused on men from the ACLS prospective cohort. The ACLS 
participants were recruited from patients attending the Cooper Clinic in Dallas, TX for a 
preventive medical examination and health behavior counseling. The participants 
completed a baseline examination at the Cooper Clinic from 1979-2002. Men were 
included in the analyses if they were between the ages of 30-74 years, had a BMI  ≥18.5 
kg/m
2
, were free of a previous CHD, cancer, or stroke diagnosis at baseline, reached a ≥ 
85% age-predicted maximal exercise heart rate at each visit, and had complete data with 
a minimum of one year of follow-up. Figure 1 displays the inclusion and exclusion 
criteria for this study. 
 
Clinical Examination 
Standardized protocols were followed by trained technicians at every clinical 




Other clinical baseline measures included a 12-hour fasting cholesterol and glucose 
measurement, blood pressure assessment, electrocardiogram, anthropometric 
measurements, and a maximal exercise test. 
112,164,166
 A standardized questionnaire was 
used to capture an individual’s current smoking status and medical history.  
 
Measures 
Definition of Outcome  
CHD was defined either by self-reported myocardial infarction (MI), bypass, 
coronary balloon, angioplasty, or stent placement, or by CHD mortality. Self-reported 
history of CHD was collected through a mail-back survey administered in 1982, 1986, 
1990, 1995, 1999, and 2004. CHD specific mortality was determined through linking the 
ACLS cohort with the National Center for Health Statistic’s National Death Index. The 
primary cause of death was determined by International Classification of Disease Ninth 
(ICD-9) and Tenth (ICD-10) revisions. CHD mortality was classified with ICD-9 codes 
410.0-414.0 and ICD-10 codes I20-I25. In accordance with FRS’s follow-up definition, 
the cut-off for maximum follow-up time for CHD event was 12 years. 
 
Primary Exposure  
Estimated CRF (e-CRF) was expressed in metabolic equivalent of task (MET) 
units. METs were estimated using a 6-item questionnaire. 
170,174
 The sex-specific 
questionnaire is composed of a participant’s age, BMI, waist circumference (WC), resting 
heart rate (RHR), two-level physical activity (activity), and smoking status (smoke). 
These variables are applied to Jackson et al’s algorithm 
171
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The estimated METs were categorized into three age-adjusted e-CRF tertiles: low, 




Application of Framingham Risk Score 
A composite 10-year CHD risk score was generated for each participant using the 
FRS. The FRS was derived from the Framingham Heart Study and the 1998 modeling 
113
 
to predict 10-year CHD risk. The FRS is a sex-specific and age-adjusted risk score that 
incorporates categorical variables for blood pressure, total cholesterol, high density 
lipoprotein cholesterol (HDL-C), diabetes diagnosis, and smoking status. Point values 
were tabulated for each participant based on Wilson et al’s study 
113
 and the cohort was 
stratified based on their ‘low’ or ‘moderate or high’ 10-year FHS predicted CHD risk. A 




Descriptive statistics were calculated for the total study population and stratified 
by e-CRF. Chi-square tests and Cochran Armitage trend tests were conducted to 
determine significant differences between the e-CRF levels and each risk factor. Death 
rate per 10,000 person-years for follow-up was calculated for e-CRF and 10-year FHS 




examination year, were generated to determine the association between e-CRF and CHD, 
and the relationship between 10-year FHS predicted CHD risk and actual CHD events. A 
fully adjusted Cox Proportional Hazard Model was used to determine the relationship 
between e-CRF, 10-year FHS predicted CHD risk and CHD. The effect of e-CRF on 
CHD also was investigated on population subsets defined by age, smoking status, 
hypertension status, and diabetes diagnosis. To investigate if there was a significant 
interaction between e-CRF and 10-year FHS predicted CHD risk, the male ACLS 
participants were stratified by ‘low’ or ‘moderate or high’ FHS predicted CHD risk and 
hazard ratios between e-CRF and CHD were calculated. The receiver operating 
characteristic (ROC) curves were plotted to determine if there was a significant 
improvement in the predictive accuracy of CHD by augmenting the FRS point 
summation with e-CRF. The chi-square test determined if there was a significant 
difference between the models. The Hosmer-Lemeshow statistics was used to asses 
calibration and goodness of fit; the statistics compares the predictive and observed events 
but is limited to sample sizes smaller than 10,000 observations. 
169
 To control for this 
limitation, a random sample population was generated from the larger study population to 
perform this goodness of fit test. SAS
®
 version 9.3 was used to perform all descriptive, 
survival, and predictive analyses.  
 
Results 
There were 499 CHD events among 29,854 men (contributing 248,890 person-
years of observation) (Figure 6.1). Table 1 displays the comparisons between men 




compared to high fit men. Men with low e-CRF were also less likely to have optimal or 
normal blood pressure compared to men with moderate or high e-CRF. High-fit men 
were more likely to have increased levels of HDL-C ≥60 mg/dL, be nondiabetic, and be a 
nonsmoker compared to moderate or low-fit men.  
 
Crude survival analysis, adjusted for baseline examination year, reported that both 
e-CRF and ‘moderate or high’ 10-year FHS predicted CHD risk were statistically 
significant with CHD (Table 6,2). In the crude Cox analysis, men with high e-CRF had a 
36% (HR=0.64; 95% CI 0.51, 0.80) lower CHD risk compared to low fit men (p-value 
for trend <0.001). This significant association between e-CRF and CHD remained in a 
subsequent model controlling for ‘moderate or high’ 10-year FHS predicted CHD risk, 
although effect size was slightly attenuated. The significant protective effect between e-
CRF and CHD was also found in subpopulations of male ACLS cohort members. Figure 
2 reports that among men age ≥ 60 years, high fitness reduced CHD risk by 44% 
(HR=0.56; 95% CI 0.32,  0.97). Among non-smokers, men within the highest fitness 
tertile (HR=0.62; 95% CI 0.48, 0.79) had a smaller probability of a CHD event compared 
to non-smokers with low e-CRF. Although similar protective effects were present for the 
different classifications of hypertension, high e-CRF proved to be significantly protective 
against CHD in men with optimal blood pressure. 
 
Figure 6.3 portrays the association between e-CRF and CHD stratified by ‘low’ 
and ‘moderate or high’ FHS predicted CHD risk. Men with ‘low’ 10-year FHS predicted 




compared to men with low 10-year FHS predicted CHD risk and low e-CRF. In men with 
‘moderate or high’ 10-year FHS predicted CHD risk, men with middle e-CRF were 38% 
(HR=0.62; 95% CI 0.32, 1.22) less likely to experience a CHD incident event compared 
to men with low e-CRF. High e-CRF also was associated with a protective effect 
(HR=0.69; 95% CI 0.31, 1.51) of CHD in men with ‘moderate or high’ FHS predicted 
CHD risk, although neither relationship was not statistically significant.  
 
The receiver operating characteristic (ROC) curves were plotted for ‘FRS point 
summation only’  model and the ‘FRS point summation with e-CRF’ (Figure 6.4). The 
Area Under the Curve was higher for the ‘FRS point summation with e-CRF’ (c-
statistic=0.7987; 95% CI 0.7813, 0.8161) compared to the model ‘FRS point summation 
only’ (c-statistic=0.7972; 95% CI 0.7798, 0.8146). The predictive power of these models 
was not significantly different (p-value=0.90) but the goodness of fit test reported that the 




Men with middle or high e-CRF were at a significantly lower risk for CHD 
compared to men with low e-CRF. Among men with ‘low’ FHS predicted risk for CHD, 
high fit men had a significantly lower risk for CHD compared to men with low fitness. 
To our knowledge, this is the first study to examine the relationship between e-CRF and 
CHD and the protective effect of e-CRF on CHD among men with ‘moderate or high’ 





The FRS has been validated in various populations with similar results to ours. 
Male physicians in the US, enrolled in the Physician’s Health Study, reported their 
coronary risk factors through a questionnaire at enrollment and completed follow-up 
surveys every 6 months to capture CHD incidence. 
27
 The study found similar risk factors 
associated with CHD as those reported in the Framingham Heart Study, with the 
exception of smoking status. Additionally, D’Agostino et al conducted a comparison 
analysis to determine the level of agreement between the FRS applied to the Framingham 
Heart Study cohort and the FRS applied to non-Framingham Heart Study populations. 
They concluded that the level of agreement was reasonably sound between the predicted 





For the purposes of our study, ‘moderate or high’ CHD risk was defined through 
the 1998 FRS that quantified categorically-defined risk factors in to a composite score. 
113
 
The age-adjusted composite score included CHD risk factors of hypertension, 
hypercholesterolemia, diabetes diagnosis, and smoking status. Many researchers report 
that the decrease in CHD-related mortality and CHD incidence could be attributed to the 
modification of these risk factors through prevention and close monitoring, 
improvements of modifiable lifestyle characteristics, 
9,10
 and pharmacologic treatment of 







Similar to the FRS, which was comprised by several risk factors, CRF also is a 
significant predictor of CHD and a modifiable risk factor. The Lipid Research Clinics 
Prevalence Survey 
45
 divided approximately 4,000 men in to a healthy and unhealthy 
group. Their investigation found that healthy men with high CRF had a lower risk for 
CHD mortality compared to men with low CRF; unhealthy men with a history of CVD 
and low CRF were 5.6 times more likely to die from CHD compared to men with a 
history of CVD and high CRF. 
45
 CRF’s protective effect on CHD can be explained 
through moderate and high fit individual’s having increased muscle mass 
152
, enhanced 
arterial oxygen content, 
152,153
 improved glycemic control, 
66
 increased double-product 
threshold for ischemic ST-segment depression, 
154,155
 and may protect against thrombosis 
187
 Several studies have reported on the modifiable qualities of CRF in various 
populations. 
47,188-190
 Oja et al’s reported the significant improvement of heart rate 
recovery and maximal oxygen uptake (traditionally used to determine CRF) 
47
 after an 
18-month, exercise training program. A meta-analysis reported similar findings to Oja et 
al’s and concluded that exercises, varying in duration and intensity, also improved CRF 




The current study expands on previous literature by investigating the protective 
effects of e-CRF on CHD. Estimated CRF offers the predictive capability of traditionally 
measured CRF 
170
 while reducing the cost/burden to the patient and clinician. As stated 
above, improvements in fitness as estimated by e-CRF may lead to additional 
improvements in other CHD risk factors such as hypertension and glycemic control and 





The limitations of this study should be noted and considered when determining 
generalizability. Due to the small number of CHD events occurring in women, only men 
were included in the present analysis. Future research should investigate the association 
between e-CRF and CHD in asymptomatic women. The non-significant association 
between e-CRF and CHD among stage II-IV hypertensive men may be due to the small 
proportions and generalizations toward this group should also be made cautiously. It also 
should be noted that the ACLS cohort consists predominately of non-Hispanic White 
individuals from middle to upper socioeconomic status who were relatively young (i.e., 
with a mean age of 42 years). Although this limitation may be considered a strength 
because of its tendency to improve internal validity while exerting inherent control for 
possible demographic confounders, generalizations and implementations of e-CRF 
should be made cautiously. 
 
Conclusion 
Our study found that among men with ‘low’ risk for CHD by the FRS, those with 
high fitness had a lower risk for CHD when compared to men with low fitness. Increasing 
awareness through early quantification of a patient’s risk for CHD is important for CHD 
prevention. Although the FRS is a validated tool that enables physicians to assess an 
individual’s risk, many clinicians have questioned the ability of the FRS to add to the 
standard overall clinical evaluation. Our results suggest that an assessment of e-CRF may 
add considerably to the clinicians’ overall risk assessment for CHD. The results of this 6-




smoking status) which can be quickly and easily collected during a clinical exam by 
paramedical staff, can help clinicians predict adverse CHD events and provide 
ammunition for the promotion of physical activity and exercise training for improving 































Age, range (years) 30-74 30-74 30-74 30-70  
Mean Age, y 44.7 49.7 46.8 42.1 <0.001 
Moderate or High 10-
year CHD risk 
2.1 3.7 1.7 0.8 <0.001 
Blood Pressure, mm 
HG 
     
Optimal                                                 
(SBP<120, DBP<80) 
28.8 16.6 29.4 40.4 <0.001 
Normal                                                           
(SBP <130, D<85) 
31.8 29.2 33.7 32.6 <0.001 
High Normal                                           
(SBP <140, DBP<90) 
16.0 18.6 16.1 13.2 <0.001 
Stage I HTN                                                             
(SBP <160, DBP<100) 
18.7 26.9 17.4 11.9 <0.001 
Stage II-IV HTN                
(SBP ≥160, DBP≥100) 
4.7 8.7 3.4 1.9 <0.001 
Total Cholesterol, 
mg/dL 
     
<160 9.2 6.8 8.2 12.5 <0.001 
160-169 34.1 28.7 33.3 40.3 <0.001 
200-239 36.9 38.5 37.9 34.3 <0.001 
240-279 15.3 19.6 15.7 10.6 <0.001 
≥280 4.5 6.4 4.8 2.3 <0.001 
HDL-C, mg/dL      
<35 15.6 24.8 14.2 7.9 <0.001 
35-44 34.1 39.9 36.0 26.5 <0.001 
45-49 15.6 13.8 16.7 16.2 <0.001 
50-59 21.4 15.1 21.4 27.7 <0.001 




Abbreviations: DBP, diastolic blood pressure; e-CRF, estimated cardiorespiratory 









Diabetes 1.4 2.8 0.9 0.6 <0.001 







Table 6.2. Adjusted survival risks for coronary heart disease (CHD) events by estimated 
cardiorespiratory fitness (e-CRF) or 10-year CHD risk group 














Estimated CRF  
(e-CRF)      
Low 5970 152 31.93 1 1 










P value for trend 
   
<0.001 0.003 
10-year CHD Risk 
     
Low 29241 447 18.34 1 1 





Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio 
 
*Deaths per 10,000 person-years of follow-up adjusted for examination year 
† 
Adjusted for examination year 
‡ 









Figure 6.1. Inclusion criteria for the study population from the 
Aerobic Center Longitudinal Study (ACLS) inclusion criteria 
depicting final sample size and coronary heart disease (CHD) 
event frequency. Men with complete Framingham Risk Score 
(FRS) data, estimated cardiorespiratory fitness (e-CRF) data, 
and body mass index (BMI) ≥ 18.5 kg/m
2




























































































Figure 6.2. Multivariable adjusted hazard ratio and 95% confidence intervals for 
estimated cardiorespiratory fitness (e-CRF) and coronary heart disease (CHD) events 










































1.00 0.76 0.41 1.00 0.50 0.62
 
 
Figure 6.3. Adjusted survival analysis to determine the association between estimated 
cardiorespiratory fitness (e-CRF) and risk of CHD. Population was stratified by ‘low’ and 
‘moderate or high’ 10-year Framingham Heart Study (FHS) predicted CHD risk to 






















B. Framingham Risk Score 




Figure 6.4. Receiver Operating Characteristic Curve comparing the 
predictive ability of the Framingham Risk Score (FRS) point summation 
(Model A) compared to the Framingham Risk Score point summation and 
estimated cardiorespiratory fitness (e-CRF) (Model B). Both models were 
applied to the ACLS cohort with a 12 year follow-up. The Hosmer-
Lemeshow c-statistic is represent by the Area Under the Curve for Model 
A(c=0.7972; 95% CI 0.7798, 0.8146) and B (c=0.7987 95% CI 0.7813, 
0.8161) with no significant difference (p=0.9046). The chi-square test for 










Coronary heart disease (CHD) incidence has decreased worldwide in the past 30 years. 
7,8
  
Age-adjusted CHD mortality has decreased in the U.S., 
184
 and self-reported prevalence 
in the U.S. has also decreased 
185
 from 2006-2010. Despite these statistics, CHD still 
remains one of the leading causes of death in the U.S. 
186
 The Framingham Risk Score 
(FRS) is an age-adjusted, sex-specific composite score that incorporates CHD risk factors 
such as hypertension, hypercholesterolemia, diabetes diagnosis, and smoking status. The 
FRS does not include cardiorespiratory fitness (CRF), a factor consistently shown to have 
a protective effect on CHD 
45,46
 and other adverse outcomes. 
34,43,88,127,141
 
The purpose of this research was to validate the FRS in the Aerobics Center 
Longitudinal Study (ACLS) cohort; update and improve the predictability of the FRS 
through the addition of CRF while resolving limitations in previous studies; and assess 






PAPER 1: Framingham Risk Score applied to the Aerobic Center Longitudinal 
Study (ACLS) 
Risk factor scores, have been developed to help clinicians quantify their patient’s 
CHD risk, 
18,23,113
 and the FRS is the most commonly used. 
24
 Although the FRS has been 
validated in various populations, 
6,26,175
 most lacked congruency with FRS methodology 
or had small sample sizes. This paper aimed to improve upon recent literature by strictly 
applying the FRS to the large ACLS cohort. We hypothesized that the FRS would be 
significantly predictive of CHD events for men within the ACLS population. 
 
Data collected from men (n=34,557) in the ACLS cohort were used to complete 
the multivariable survival analysis and determine the relationship between FRS variables 
and 10-year CHD risk. The FRS variables included age, systolic and diastolic blood 
pressure, total cholesterol, high density lipoprotein cholesterol (HDL-C), diabetes 
diagnosis, and smoking status. The analysis found that the FRS variables applied to the 
ACLS cohort had similar results compared to the original publication, 
113
 with a 
predictive statistic of 0.77 (95% CI 0.75, 0.79). This study further validates the FRS 
predictive ability of 10-year CHD risk although limitations still exist. To control for 
potential limitations, future research should focus on the expansion of the FRS to include 





PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic 
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness 
(CRF) 
The FRS provides a sex-specific, age-adjusted risk score that accounts for systolic 
and diastolic blood pressure, total cholesterol, high density lipoprotein cholesterol, 
diabetes diagnosis, and smoking status. 
25
 Previous studies 
29,30,104
 have modified the FRS 
to include additional risk factors. None of these modifications involved the addition of 
cardiorespiratory fitness (CRF),  a characteristic that has shown significant protective 
effects for all-cause mortality, 
43,136
 cancer-related mortality, 
139





 and mortality. 
25,45,46
 In this paper, we aimed to expand on previous 
literature by modifying FRS with CRF and hypothesized that CRF would improve the 
FRS predictive ability of CHD events for men within the ACLS population.  
 
The ACLS cohort was utilized for this analysis and included men who completed 
a baseline examination between 1970 and 2003 (n=29,854). FRS was applied as a 
composite score to each participant and a binomial (‘low’ and ‘moderate or high’) 10-
year CHD risk was determined. Multivariable Cox Regression analysis was used to 
determine the relationship between CRF, FRS, and CHD. The population also was 
stratified by ‘low’ and ‘moderate or high’ risk for CHD to test for interaction between 
CRF and FRS. The study concluded that men within the ‘low’ 10-year CHD risk strata 
and moderate (HR=0.92 95% CI 0.68, 1.25) or high (HR=0.62, 95% CI 0.45, 0.84) CRF 




low CRF (p-value <0.001). CRF is a modifiable risk factor with a protective association 
with CHD. It may be advantageous for clinicians to evaluate a patient’s CRF to provide a 
more accurate assessment of the 10-year risk for CHD. 
 
 
PAPER 3: Determine the association between non-exercise estimated CRF (e-CRF) 
and CHD. Utilize e-CRF and FRS to predict the risk of CHD. 
Determining a patient’s risk for CHD early is important to primary prevention. 
The FRS was developed to assist physicians in completing this task. The FRS’ predictive 
power has been consistent in various populations 
26,27
 and additions of various risk factors 
29,30,106
 but some physicians still believe the FRS does not provide additional clinical 
value 
24
. CRF’s significant predictive effects on CHD have also been well documented, 
however, until recently, CRF was not easily ascertained in a clinical setting 
170
. Our aim 
for this study was to improve on the FRS and CRF limitations by analyzing non-exercise 
estimated CRF (e-CRF) with FRS to predict 10-year CHD.  
Men (n=29,854) in the ACLS cohort who completed a baseline examination at the 
Cooper Clinic in Dallas, TX were included in the analysis. Crude and adjusted Cox 
Proportional Hazard Ratios were calculated for the association between estimated CRF 
(e-CRF), FRS, and CHD. The relationship between e-CRF and CHD was also analyzed in 
subsets of the population based on age, smoking status, hypertension, and diabetes 
diagnosis. To test for interaction between e-CRF and FRS, a survival analysis between e-




10-year CHD risk. Our main finding from these analyses was that among men with 
‘moderate or high’ risk for CHD, men with moderate e-CRF were 50% (HR=0.50; 95% 
CI 0.28, 0.89) less likely to experience a CHD incident compared to men with low e-
CRF. A secondary finding was that the significant protective effect e-CRF has on CHD 
among population subsets. Among current smokers, men with moderate e-CRF 
(HR=0.52; 95% CI 0.32, 0.84) or high CRF (HR=0.37; 95% CI 0.22, 0.65) had a smaller 
probability of a CHD event compared to current smokers with low e-CRF.  This study 
provides additional clinical value to the FRS by augmenting the traditional risk score 
with e-CRF.  
 
OVERALL DISCUSSION AND FINDING 
CHD is one of the leading causes of death in the U.S. and early establishment of 
CHD risk is important for primary and secondary prevention. The FRS encompasses 
some of CHD’s major risk factors, except CRF is not included. A recent study provided 
researchers and clinicians with a tool to determine a patient’s non-exercise estimated 
CRF through a 5-item scale. The series of papers presented in this dissertation provide 
the evidence needed to establish a more comprehensive and clinically feasible CHD risk 
prediction tool. This research concludes that the FRS was consistently predictive of 10-
year CHD events. FRS’s effect is improved through the addition of CRF to provide a 
more clinically accurate prediction of individual 10-year CHD risk. Clinicians may want 
to consider capturing their patients’ medical history, CHD risk factors, and their e-CRF 




approach can help physicians predict adverse events for their patients while also 
counseling them on how to improve their overall health through improvement of CRF. 
 
FUTURE DIRECTIONS AND RESEARCH 
There are several research ideas that stem from the presented conclusions. To 
further the presented results in each of the three papers, the analysis should be replicated 
for females. FRS 
104
 and CRF 
42,85
 have both been shown to have significant associations 
with CHD and other outcomes but the combined association with FRS and CRF should 
be assessed with the CHD outcome in women.  To improve the external validity of our 
findings, the association between FRS, CRF, and CHD will need to be investigated in 
women.  
Future studies may want to replicate these FRS analyses using D’Agostino et al’s 
176
 2008 version, which focuses on cardiovascular disease (CVD) as an outcome which 
encompasses CHD diagnosis, as well as stroke and coronary artery disease. Although 
CHD comprises the majority of CVD diagnoses, utilizing a CVD risk score may provide 
a prediction with broader implications but may be potentially less accurate.  
Furthermore, e-CRF relationship with other adverse outcomes should be explored. 
Since Jurca et al 
170
 published the non-exercise e-CRF scale, the scale has been validated 
191
 and applied to selective populations such as older adults 
192
. The measurement of e-
CRF may provide significant interpretations for both research and clinical settings. Future 
clinical research should focus on capturing e-CRF to analyze effects on short and long-
term outcomes. CRF’s ability to be modified through exercise 
47,137




CHD risk factors such as glycemic control an cholesterol make e-CRF a very useful 
measure for the clinical setting. 
CONCLUSION 
This dissertation involved implementing sophisticated, predictive modeling to 
determine the association between CRF, FRS, and CHD. The statistical analyses were 
based on a subset of data from ACLS, a large cohort derived from the patients of the 
Cooper Clinic in Dallas, TX. The information and interpretations gained from this 
research provide further comprehension of FRS and CRF as well as suggestions for new 
clinical protocols for physicians to consider. We stress the importance of a 
comprehensive medical approach while balancing the burden placed on the physician and 
patient. We believe that e-CRF is an accurate assessment tool for CHD independent of, 
and jointly with FRS, and should be implemented in the clinical setting. 
This dissertation process was a valuable experience that enhanced my 
appreciation of academia and clinical research. My dissertation challenged me 
academically to apply and interpret statistical methodology I had not previously learned. 
The receiving operating characteristic (ROC) curve helps determine the predictability of 
a model on the outcome of interest and was applied to each of the three manuscripts. I 
had to go beyond the simple application of the ROC curve and determine if this analytical 
method was appropriate for the data by examining the ROC curve’s strengths and 
limitations. Fortunately, academia recognizes the necessity for collaboration to generate 




a new statistical method easier because it enabled me to consult with other researchers 
and gain their perspective on this method and the best approaches.  
Collaborating can also save time and provide motivation to complete a project. 
When I initiated my dissertation and began to formulate my scope and specific aims, I did 
not fully appreciate the limiting ability of data or other student’s work-in-progress. After 
review of the published literature and months developing potential aims, I drafted and 
discussed a miniature proposal with my chair and co-chair. This collaboration helped me 
refine my specific aims, determine the potential variables that were available for analysis, 
and learn about the ongoing projects my peers were investigating in the ACLS cohort. 
Without this collaboration, I might have spent a few more months developing hypotheses 
that could not be investigated in ACLS or that another researcher was already developing.  
Throughout my time spent obtaining my doctoral degree, I began my transition 
from an epidemiology student to a career as a junior epidemiologist. Part of this transition 
encompassed enhanced partnership with physicians and medical staff. My involvement 
with clinical research has forced me to acknowledge limitations such as imperfect data 
and limited sample size while capitalizing on the strength of the data. The enhanced 
appreciation for clinical research while still working with a large, prospective cohort 
provided me the opportunity to engage in the full spectrum of study designs. With 
encouragement from my dissertation committee and my clinical research colleagues, I 
have begun developing research projects to apply the knowledge and research experience 




This dissertation process has served as a hands-on learning experience that 
enhanced my epidemiological and statistical knowledge, improved my analysis and 
research skills, and enabled me to bridge my past research interests and experience with 
new opportunities.   I hope to continue my work with both the University of South 
Carolina and my clinical research team to help integrate estimated cardiorespiratory 
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